triiodothyronine has been researched along with Thyrotoxicosis in 241 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
Excerpt | Relevance | Reference |
---|---|---|
"Iodine-induced hyperthyroidism and triiodothyronine (T3) thyrotoxicosis in patients who routinely gargle with povidone-iodine (PVP-I) gargling solution are rare in Japan." | 9.41 | Povidone-iodine-induced transient triiodothyronine thyrotoxicosis in a Japanese patient with prolonged habitual gargling: A case report and literature review. ( Suzuki, R; Suzuki, S, 2023) |
"Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders." | 9.12 | Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Rossi, G; Tanda, ML; Tomisti, L, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) may occur either in the presence of underlying thyroid disease (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 9.10 | Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Dell'Unto, E; Grasso, L; Martino, E; Pinchera, A; Rossi, G, 2003) |
" To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 9.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
"Carbimazole, in 3 divided daily doses, is commonly prescribed for the treatment of thyrotoxicosis." | 9.07 | Comparison of the efficacy of single and multiple regimens of carbimazole in the treatment of thyrotoxicosis. ( Mafauzy, M; Mustafa, BE; Wan Mohamad, WB; Zahary, MK, 1993) |
"To determine whether thyrotoxicosis has an effect on the asthmatic state in subjects with mild asthma, airway responsiveness, lung function, and exercise capacity were measured in a randomized double-blind placebo-controlled trial before and after liothyronine (triiodothyronine, T3)-induced thyrotoxicosis." | 9.07 | Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness. ( Braverman, LE; Dubois, JM; Hollingsworth, HM; Irwin, RS; Pratter, MR, 1991) |
"Amiodarone-induced thyrotoxicosis (AIT) affects up to 3% of treated patients." | 7.91 | Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis. ( Campi, I; Fugazzola, L; Groppelli, A; Parati, G; Perego, GB; Persani, L; Ravogli, A, 2019) |
"To study the effect of a iodine load on thyroid function of patients with ischaemic heart disease (IHD) and the long-term influence of unknown subclinical hyperthyroidism." | 7.88 | Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status. ( Anselmino, M; Bonelli, N; Castagno, D; Gaita, F; Garberoglio, R; Ghigo, E; Grimaldi, R; Maccario, M; Parasiliti Caprino, M; Rossetto, R; Vignolo, F, 2018) |
"Amiodarone is associated with thyroid dysfunction and life-threatening thyrotoxicosis." | 7.80 | Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report. ( Ariano, RE; Dostmohamed, H; Houston, DS; Katz, P; Knoll, C; Lewis, B; Schacter, I; Yamamoto, J; Zarychanski, R, 2014) |
"The identification of the different subtypes of amiodarone-induced thyrotoxicosis (AIT) may provide a rational basis for the choice of the appropriate medical treatment." | 7.76 | Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake. ( Atalay, S; Berberoğlu, M; Hacihamdioğlu, B; Oçal, G; Savaş Erdeve, S; Siklar, Z; Tutar, E, 2010) |
"In SWG, a recently iodine-sufficient region, the risk of developing hyperthyroidism in patients with NTNG after administration of 100-150 microg T4 is relatively high in those whose serum TSH before T4 treatment is in the lower normal range." | 7.74 | The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency. ( Kyriazopoulou, V; Markou, KB; Michalaki, M; Paraskevopoulou, P; Vagenakis, AG, 2008) |
"We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 7.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
"Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 7.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
"We report the case of a 60 year old female patient on continuous systemic anticoagulation therapy with coumarin due to mechanical aortic valve replacement and a more than 3 years lasting amiodarone therapy due to severe ventricular extrasystoles suffering from amiodarone induced thyrotoxicosis (AIT)." | 7.74 | Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. ( Biersack, HJ; Brockmann, H; Bucerius, J; Ezziddin, S; Palmedo, H, 2007) |
"3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 7.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
"Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
"Although there are two types of amiodarone-induced thyrotoxicosis (AIT), only type II AIT has been seen at our institution in Japan so far." | 7.73 | Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Onoda, N; Sato, K; Shiga, T; Takano, K, 2006) |
"We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 7.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
" To investigate the hyperphagic response to triiodothyronine (T(3))-induced thyrotoxicosis, adult male rats were studied 7 days after daily intraperitoneal injections of T(3) or vehicle." | 7.72 | Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis. ( Ishii, S; Kamegai, J; Oikawa, S; Shimizu, T; Sugihara, H; Tamura, H, 2003) |
"Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 7.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
"In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 7.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
"A 45-year-old women with chronic idiopathic thrombocytopenic purpura was given monthly injections of the GnRH agonist leuprolide acetate for the treatment of uterine leiomyoma." | 7.70 | Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. ( Kasayama, S; Miyake, S; Samejima, Y, 2000) |
"A patient with amiodarone-induced thyrotoxicosis and autonomous nodule was treated with percutaneous ethanol injection (PEI) in 8 sessions." | 7.69 | Percutaneous ethanol injection therapy of autonomous nodule and amiodarone-induced thyrotoxicosis. ( Caraccio, N; Casolaro, A; Del Guerra, P; Franchi, F; Monzani, F; Pucci, E, 1994) |
"We evaluated the value of serum-free thyroid hormone and thyrotropin (TSH) concentrations in the detection of peripheral hyperthyroidism during thyroxine suppression therapy." | 7.69 | Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients. ( Irjala, K; Koskinen, P; Nikkanen, V; Nuutila, P; Saraste, M; Taimela, E; Taimela, S, 1995) |
"To develop a strategy to identify cases of endogenous subclinical hyperthyroidism and free triiodothyronine (free T3) thyrotoxicosis in otherwise healthy ambulatory patients." | 7.69 | The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis. ( Figge, J; Gates, S; Goodman, AD; Izquierdo, R; Lee, DW; Leinung, M; Line, B; Mydosh, T, 1994) |
"In 35 infants of lactating mothers with thyrotoxicosis who were receiving 5 to 20 mg methimazole daily, serum levels of thyroxine, triiodothyronine, thyrotropin were within normal ranges 1 month after the start of breast-feeding." | 7.69 | Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. ( Azizi, F, 1996) |
"Amiodarone-induced thyrotoxicosis (AIT) occurs in both abnormal (type I) and apparently normal (type II) thyroid glands due to iodine-induced excessive thyroid hormone synthesis in patients with nodular goiter or latent Graves' disease (type I) or to a thyroid-destructive process caused by amiodarone or iodine (type II)." | 7.69 | Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. ( Bartalena, L; Bogazzi, F; Brogioni, S; Burelli, A; Grasso, L; Martino, E, 1996) |
" Missense mutations of the TTR gene produce familial amyloidotic polyneuropathy and rarely, euthyroid hyperthyroxinemia (EHT)." | 7.69 | A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study. ( Byrne, MM; Marinov, VS; Refetoff, S; Sunthornthepvarakul, T; Tunca, H; Weiss, RE, 1996) |
"To document circulating total thyroxine (T4) and triiodothyronine (T3) responses after administration of thyrotropin (thyroid-stimulating hormone [TSH]) to hyperthyroid and healthy cats and assess the value of these responses as an additional diagnostic test for hyperthyroidism." | 7.69 | Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin. ( Doxey, DL; Mooney, CT; Thoday, KL, 1996) |
"Elevation of the plasma adrenomedullin and proadrenomedullin-N terminal 20-peptide levels raises the possibility of involvement of these vasodilatory peptides in the haemodynamic changes in thyrotoxicosis." | 7.69 | Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis. ( Ban, Y; Ito, K; Katagiri, T; Kitamura, K; Sugita, E; Taniyama, M, 1997) |
"The present report illustrates the clinical and biochemical outcome in two amiodarone iodine-induced thyrotoxicosis (AIIT) patients submitted to plasmapheresis." | 7.68 | Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. ( Aghini-Lombardi, F; Braverman, LE; Fosella, PV; Grasso, L; Mariotti, S; Martino, E; Pinchera, A, 1993) |
"In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 7.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
"Amiodarone-induced thyrotoxicosis (AIT) is generally believed to result from increased hormonal synthesis related to the iodine overload." | 7.68 | Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. ( Brohet, C; De Nayer, P; Gangji, D; Lambert, M; Unger, J, 1990) |
" To examine changes in polyol metabolism in hyperthyroidism, we investigated changes in erythrocyte sorbitol, glyceraldehyde reductase (GAR) and sorbitol dehydrogenase (SDH) activities during hyperthyroid and euthyroid states in patients with thyrotoxicosis." | 7.68 | [Erythrocyte sorbitol levels in patients with thyrotoxicosis]. ( Hosojima, H; Miyauchi, E; Morimoto, S; Okada, H, 1990) |
"A rare case of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with nonthyroidal illness is reported." | 7.67 | Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness. ( Balestrieri, A; Balzano, S; Bartalena, L; Cherchi, A; Martino, E; Ruscazio, M; Sau, F, 1987) |
"Iodine-induced hyperthyroidism and triiodothyronine (T3) thyrotoxicosis in patients who routinely gargle with povidone-iodine (PVP-I) gargling solution are rare in Japan." | 5.41 | Povidone-iodine-induced transient triiodothyronine thyrotoxicosis in a Japanese patient with prolonged habitual gargling: A case report and literature review. ( Suzuki, R; Suzuki, S, 2023) |
"McCune-Albright syndrome (MAS) is caused by mutations in GNAS (most often R201C or R201H) leading to constitutive cAMP signaling and multiple endocrine dysfunctions, including morphological and functional thyroid involvement." | 5.35 | The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome. ( Brillante, BA; Celi, FS; Cherman, N; Chidakel, A; Collins, MT; Coppotelli, G; Feuillan, PP; Kelly, M; Shawker, T, 2008) |
"Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 5.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
"Isoniazid acetylation was assessed in 10 thyrotoxic patients before and after standard antithyroid therapy." | 5.27 | The effect of thyrotoxicosis on isoniazid acetylation. ( Hutchings, A; Lazarus, JH; Littley, MD; Routledge, PA; Spragg, BP, 1988) |
"Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders." | 5.12 | Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Rossi, G; Tanda, ML; Tomisti, L, 2007) |
" In view of the increased enterohepatic circulation of thyroxine (T4) and triiodothyronine (T3) in thyrotoxicosis, and metabolic effects of konjac glucomannan in gastrointestinal system, we aimed to determine the activity of glucomannan in treatment of hyperthyroidism." | 5.12 | The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. ( Azezli, AD; Bayraktaroglu, T; Orhan, Y, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) may occur either in the presence of underlying thyroid disease (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 5.10 | Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Dell'Unto, E; Grasso, L; Martino, E; Pinchera, A; Rossi, G, 2003) |
" To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 5.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
"Carbimazole, in 3 divided daily doses, is commonly prescribed for the treatment of thyrotoxicosis." | 5.07 | Comparison of the efficacy of single and multiple regimens of carbimazole in the treatment of thyrotoxicosis. ( Mafauzy, M; Mustafa, BE; Wan Mohamad, WB; Zahary, MK, 1993) |
"To determine whether thyrotoxicosis has an effect on the asthmatic state in subjects with mild asthma, airway responsiveness, lung function, and exercise capacity were measured in a randomized double-blind placebo-controlled trial before and after liothyronine (triiodothyronine, T3)-induced thyrotoxicosis." | 5.07 | Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness. ( Braverman, LE; Dubois, JM; Hollingsworth, HM; Irwin, RS; Pratter, MR, 1991) |
"We compared the efficacy of diltiazem and propranolol in a randomized, prospective, double-blind, crossover study in six patients with untreated thyrotoxicosis (mean age 31 yrs)." | 5.06 | Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms. ( Davies, TF; Fuster, V; Gelman, KM; Goldman, ME; Milner, MR; Phillips, RA, 1990) |
"Overt thyrotoxicosis is defined as elevated serum free thyroxine (FT4) and free triiodothyronine (FT3), and suppressed thyrotropin (TSH) concentrations." | 4.82 | [Current issues in the treatment of thyrotoxicosis]. ( Papi, G, 2005) |
"Amiodarone-induced thyrotoxicosis (AIT) affects up to 3% of treated patients." | 3.91 | Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis. ( Campi, I; Fugazzola, L; Groppelli, A; Parati, G; Perego, GB; Persani, L; Ravogli, A, 2019) |
" Low SIC was associated with increased risk for iodine deficiency and hypothyroxinemia, while high SIC was related to excess and thyrotoxicosis." | 3.91 | Serum iodine concentration in pregnant women and its association with urinary iodine concentration and thyroid function. ( Chen, W; Chen, Y; Cui, T; Gao, S; Guo, W; Pan, Z; Pearce, EN; Shen, J; Tan, L; Wang, W; Zhang, W, 2019) |
"To study the effect of a iodine load on thyroid function of patients with ischaemic heart disease (IHD) and the long-term influence of unknown subclinical hyperthyroidism." | 3.88 | Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status. ( Anselmino, M; Bonelli, N; Castagno, D; Gaita, F; Garberoglio, R; Ghigo, E; Grimaldi, R; Maccario, M; Parasiliti Caprino, M; Rossetto, R; Vignolo, F, 2018) |
" Thyroid-stimulating hormone, free triiodthyronine, free thyroxine, thyroid peroxidase antibodies, thyroglobulin antibodies were measured and ultrasound evaluation of the thyroid gland was performed in the first trimester of pregnancy and during the first year following delivery." | 3.83 | Postpartum thyroid dysfunction in women with autoimmune thyroiditis. ( Argatska, A; Nonchev, B; Orbetzova, M; Pehlivanov, B, 2016) |
"A total of 1450 ambulatory community volunteer participants in the Baltimore Longitudinal Study of Aging examined at the NIA Clinical Research Unit in Baltimore, MD, have undergone longitudinal monitoring of serum thyrotropin (TSH) and thyroid hormone (free thyroxine and free triiodothryonine) levels as well as medication use every one to four years, depending on age, between 2003 and 2014." | 3.81 | Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. ( Chia, CW; Ladenson, PW; Mammen, JS; McGready, J; Oxman, R; Simonsick, EM, 2015) |
"Amiodarone is associated with thyroid dysfunction and life-threatening thyrotoxicosis." | 3.80 | Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report. ( Ariano, RE; Dostmohamed, H; Houston, DS; Katz, P; Knoll, C; Lewis, B; Schacter, I; Yamamoto, J; Zarychanski, R, 2014) |
"To characterize thyroid hormone levels at the time of diagnosis in the nosological types of thyrotoxicosis diagnosed in the population and to analyze determinants for serum thyroxine (T4) and tri-iodothyronine (T3)." | 3.79 | Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. ( Carlé, A; Knudsen, N; Laurberg, P; Ovesen, L; Pedersen, IB; Perrild, H; Rasmussen, LB, 2013) |
"The acute onset of severe thyroid pain, rapid increase in serum Free Thyroxine Index, and thyroglobulin concentrations with a triiodothyronine to free thyroxine index ratio of < 20 to 1 were compatible with an acute onset destructive thyroiditis, likely related to direct toxicity from the iodinated contrast material." | 3.77 | Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye. ( Calvi, L; Daniels, GH, 2011) |
"The use of hemoperfusion with a charcoal filter appears to be a very important therapeutic tool for the treatment of acute and severe forms of thyrotoxicosis due to l-thyroxine intoxication." | 3.76 | Charcoal hemoperfusion in the treatment of levothyroxine intoxication. ( Gross, JL; Kreisner, E; Lutzky, M, 2010) |
"The identification of the different subtypes of amiodarone-induced thyrotoxicosis (AIT) may provide a rational basis for the choice of the appropriate medical treatment." | 3.76 | Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake. ( Atalay, S; Berberoğlu, M; Hacihamdioğlu, B; Oçal, G; Savaş Erdeve, S; Siklar, Z; Tutar, E, 2010) |
" Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
" During pregnancy, there are some alterations in thyroid gland, such as elevation of thyroxine binding globulin, increased iodium clearance in kidneys, and stimulation of thyroid gland by human chorionic gonadotropin." | 3.75 | Gestational transient thyrotoxicosis. ( Adam, JM; Albaar, MT, 2009) |
"In SWG, a recently iodine-sufficient region, the risk of developing hyperthyroidism in patients with NTNG after administration of 100-150 microg T4 is relatively high in those whose serum TSH before T4 treatment is in the lower normal range." | 3.74 | The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency. ( Kyriazopoulou, V; Markou, KB; Michalaki, M; Paraskevopoulou, P; Vagenakis, AG, 2008) |
"We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 3.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
"Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 3.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
"We report the case of a 60 year old female patient on continuous systemic anticoagulation therapy with coumarin due to mechanical aortic valve replacement and a more than 3 years lasting amiodarone therapy due to severe ventricular extrasystoles suffering from amiodarone induced thyrotoxicosis (AIT)." | 3.74 | Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. ( Biersack, HJ; Brockmann, H; Bucerius, J; Ezziddin, S; Palmedo, H, 2007) |
"3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 3.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
"Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
" However, thyrotoxicosis as defined by elevated serum-free thyroxine (FT4) or free triiodothyronine (FT3) levels together with low thyroid-stimulating hormone (TSH) levels is rare after SCT." | 3.73 | Early-onset thyrotoxicosis after unrelated cord blood transplantation for acute myelogenous leukemia. ( Asano, S; Iseki, T; Konuma, T; Nagayama, H; Ooi, J; Sato, H; Takahashi, S; Tojo, A; Tomonari, A; Tsukada, N; Yamada, T, 2006) |
"Although there are two types of amiodarone-induced thyrotoxicosis (AIT), only type II AIT has been seen at our institution in Japan so far." | 3.73 | Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Onoda, N; Sato, K; Shiga, T; Takano, K, 2006) |
"We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 3.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
" She had been undergoing treatment with methimazole for Graves's hyperthyroidism since the age of 34." | 3.73 | A case of transient central hyperthyroidism. ( Pishdad, GR; Pishdad, P; Sabzi, A, 2006) |
" We have now studied the effect of a decrease in serum T3 levels on the GH response to GHRP-6 (1 microg/kg) plus GHRH (100 microg) in 9 hyperthyroid patients before and after 15 days of treatment with iopanoic acid (3 g every 3 days) and propylthiouracil (600 mg/day)." | 3.72 | Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis. ( Lengyel, AM; Nascif, SO; Ramos-Dias, JC; Senger, MH, 2003) |
" To investigate the hyperphagic response to triiodothyronine (T(3))-induced thyrotoxicosis, adult male rats were studied 7 days after daily intraperitoneal injections of T(3) or vehicle." | 3.72 | Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis. ( Ishii, S; Kamegai, J; Oikawa, S; Shimizu, T; Sugihara, H; Tamura, H, 2003) |
"Amiodarone-induced thyrotoxicosis developed in 31 patients (49." | 3.72 | Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. ( Barbu, C; Bunghez, R; Coculescu, M; Fica, S; Trifănescu, R; Ursu, H; Vârtej, I, 2004) |
"Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 3.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
" With the diagnosis of silent thyroiditis, he was treated with propranolol." | 3.70 | Silent thyroiditis after excision of a thymoma. ( Ishida, T; Murao, S; Sato, M; Takahara, J; Yoshinouchi, T, 1998) |
"The appearance of moderate jaundice with mildly raised levels of plasma bilirubin is an uncommon complication of thyrotoxicosis and is usually accompanied by signs of right heart failure." | 3.70 | Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis. ( Babini, G; Bertello, P; Gurioli, L; Rizzi, R, 1999) |
"In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 3.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
"Endogenous subclinical thyrotoxicosis is diagnosed when a patient who is not taking exogenous thyroid hormone has a suppressed level of thyroid-stimulating hormone with normal levels of the free thyroid hormones thyroxine and triiodothyronine and other known causes of a suppressed thyroid-stimulating hormone level have been excluded." | 3.70 | The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. ( Fallon, EF; Goldstein, H; Mikhail, M; Tollin, SR; Yung, E, 2000) |
"A 45-year-old women with chronic idiopathic thrombocytopenic purpura was given monthly injections of the GnRH agonist leuprolide acetate for the treatment of uterine leiomyoma." | 3.70 | Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. ( Kasayama, S; Miyake, S; Samejima, Y, 2000) |
"The present case describes a new and unusual variant of thyrotoxicosis: transient hyperthyroxinemia following acute and massive hemorrhage into a previously normal thyroid gland." | 3.69 | Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis. ( Skowsky, WR, 1995) |
"A patient with amiodarone-induced thyrotoxicosis and autonomous nodule was treated with percutaneous ethanol injection (PEI) in 8 sessions." | 3.69 | Percutaneous ethanol injection therapy of autonomous nodule and amiodarone-induced thyrotoxicosis. ( Caraccio, N; Casolaro, A; Del Guerra, P; Franchi, F; Monzani, F; Pucci, E, 1994) |
"We evaluated the value of serum-free thyroid hormone and thyrotropin (TSH) concentrations in the detection of peripheral hyperthyroidism during thyroxine suppression therapy." | 3.69 | Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients. ( Irjala, K; Koskinen, P; Nikkanen, V; Nuutila, P; Saraste, M; Taimela, E; Taimela, S, 1995) |
"This study was undertaken in 68 thyrotoxic patients to assess the predictive value of various post treatment biochemical and immunological tests for early hypothyroidism after I131 therapy and to determine whether pretreatment with carbimazole protects against post I131 therapy hypothyroidism." | 3.69 | Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy. ( Jain, SK; Khanna, CM; Walia, RP, 1994) |
" In patients with thyrotoxicosis during Metothyrin treatment the Zn-concentration of red-blood-cells normalised about 8 weeks later than the abnormally elevated serum thyroxine and triiodothyronine levels." | 3.69 | [Zn-content of erythrocytes in overt and subclinical hyperthyroidism]. ( Földes, J; Steczek, K; Tarján, G; Varga, F, 1994) |
"To develop a strategy to identify cases of endogenous subclinical hyperthyroidism and free triiodothyronine (free T3) thyrotoxicosis in otherwise healthy ambulatory patients." | 3.69 | The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis. ( Figge, J; Gates, S; Goodman, AD; Izquierdo, R; Lee, DW; Leinung, M; Line, B; Mydosh, T, 1994) |
"Two male adolescents had subtle symptoms and signs of thyrotoxicosis but normal levels of total and free thyroxine and total triiodothyronine." | 3.69 | Free triiodothyronine toxicosis in two adolescents. ( Root, AW, 1994) |
"In 35 infants of lactating mothers with thyrotoxicosis who were receiving 5 to 20 mg methimazole daily, serum levels of thyroxine, triiodothyronine, thyrotropin were within normal ranges 1 month after the start of breast-feeding." | 3.69 | Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. ( Azizi, F, 1996) |
"Amiodarone-induced thyrotoxicosis (AIT) occurs in both abnormal (type I) and apparently normal (type II) thyroid glands due to iodine-induced excessive thyroid hormone synthesis in patients with nodular goiter or latent Graves' disease (type I) or to a thyroid-destructive process caused by amiodarone or iodine (type II)." | 3.69 | Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. ( Bartalena, L; Bogazzi, F; Brogioni, S; Burelli, A; Grasso, L; Martino, E, 1996) |
" Missense mutations of the TTR gene produce familial amyloidotic polyneuropathy and rarely, euthyroid hyperthyroxinemia (EHT)." | 3.69 | A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study. ( Byrne, MM; Marinov, VS; Refetoff, S; Sunthornthepvarakul, T; Tunca, H; Weiss, RE, 1996) |
"To document circulating total thyroxine (T4) and triiodothyronine (T3) responses after administration of thyrotropin (thyroid-stimulating hormone [TSH]) to hyperthyroid and healthy cats and assess the value of these responses as an additional diagnostic test for hyperthyroidism." | 3.69 | Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin. ( Doxey, DL; Mooney, CT; Thoday, KL, 1996) |
"Elevation of the plasma adrenomedullin and proadrenomedullin-N terminal 20-peptide levels raises the possibility of involvement of these vasodilatory peptides in the haemodynamic changes in thyrotoxicosis." | 3.69 | Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis. ( Ban, Y; Ito, K; Katagiri, T; Kitamura, K; Sugita, E; Taniyama, M, 1997) |
"The present report illustrates the clinical and biochemical outcome in two amiodarone iodine-induced thyrotoxicosis (AIIT) patients submitted to plasmapheresis." | 3.68 | Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. ( Aghini-Lombardi, F; Braverman, LE; Fosella, PV; Grasso, L; Mariotti, S; Martino, E; Pinchera, A, 1993) |
"In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 3.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
" Kit calibrators or calibrators consisting of the IRP for TSH made up in two common matrices, (1) serum from patients with untreated thyrotoxicosis or (2) serum taken from subjects treated with suppressive doses of triiodothyronine, gave similar results for the between-laboratory variation of estimates of TSH concentration for a range of serum samples." | 3.68 | The effects of common matrices for assay standards on performance of 'ultra sensitive' immunometric assays for TSH. Report of a joint WHO/IFCC collaborative study. ( Brettschneider, H; Bristow, AF; Gaines-Das, RE, 1991) |
"Amiodarone-induced thyrotoxicosis (AIT) is generally believed to result from increased hormonal synthesis related to the iodine overload." | 3.68 | Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. ( Brohet, C; De Nayer, P; Gangji, D; Lambert, M; Unger, J, 1990) |
" Authors diagnosed a rare type of thyrotoxicosis-triiodothyronine toxicosis+, which was only manifested by long-lasting supraventricular tachycardia without clinical state impairment." | 3.68 | [Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis]. ( Moszczyński, P; Słowiński, S; Zabówka, M, 1990) |
" To examine changes in polyol metabolism in hyperthyroidism, we investigated changes in erythrocyte sorbitol, glyceraldehyde reductase (GAR) and sorbitol dehydrogenase (SDH) activities during hyperthyroid and euthyroid states in patients with thyrotoxicosis." | 3.68 | [Erythrocyte sorbitol levels in patients with thyrotoxicosis]. ( Hosojima, H; Miyauchi, E; Morimoto, S; Okada, H, 1990) |
"Iodine-induced thyrotoxicosis (ITT) has not been reported in Japan." | 3.67 | [Transient thyrotoxicosis induced by Japanese kombu]. ( Ishizuki, Y; Miura, Y; Yamauchi, K, 1989) |
"To elucidate the possible role of insulin, glucagon, and epinephrine on glucose intolerance in thyrotoxicosis, the secretion of insulin and glucagon in vivo (glucose, arginine, and epinephrine infusion tests) and in perfused pancreas and the hepatic action of insulin, glucagon, and epinephrine in perfused liver were investigated in experimental thyrotoxic rats (induced by thyroxine injection, 20 micrograms/kg sc, for 7 days)." | 3.67 | Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine. ( Ikeda, T; Mashiba, H; Mokuda, O; Tominaga, M, 1988) |
"A rare case of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with nonthyroidal illness is reported." | 3.67 | Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness. ( Balestrieri, A; Balzano, S; Bartalena, L; Cherchi, A; Martino, E; Ruscazio, M; Sau, F, 1987) |
"Potassium contractures and asymmetric charge movement were recorded from extensor digitorum longus (EDL) and soleus muscle from normal rats and rats that had been made thyrotoxic by daily intraperitoneal injections of triiodothyronine (150 micrograms kg-1) for two to three weeks." | 3.67 | Potassium contractures and asymmetric charge movement in extensor digitorum longus and soleus muscles from thyrotoxic rats. ( Dulhunty, AF; Gage, PW; Lamb, GD, 1987) |
"Amiodarone is an antiarrhythmic drug frequently used in everyday clinical practice." | 2.53 | [Clinical procedure in amiodarone-induced thyroid dysfunction]. ( Cygankiewicz, I; Kosmalski, M; Michalak, R; Ptaszyński, P; Różycka-Kosmalska, M; Wranicz, JK; Zieleniewski, W, 2016) |
"Subclinical thyrotoxicosis is defined as low serum thyrotropin (TSH) and normal serum thyroid hormone concentrations." | 2.40 | Subclinical thyrotoxicosis. ( Haden, ST; Marqusee, E; Utiger, RD, 1998) |
"T3 thyrotoxicosis is a relatively rare diagnosis and fT3 measurement has limited utility in the vast majority of patients." | 1.91 | Limited Utility of Free Triiodothyronine Testing. ( Farnsworth, CW; Gronowski, AM; Lin, Y; Riek, AE, 2023) |
"If factitious hyperthyroidism is suspected, we should request thyroglobulin and anti-thyroglobulin tests, as well as a thyroid scan or uptake curve." | 1.72 | [Factitious hyperthyroidism due to intake of herbal supplements for weight reduction]. ( Cristabel Rubino, G; Kozak, A; Lovazzano, S; Ortiz, MI; Scheinfeld, G; Varsavsky, M, 2022) |
"Several reports have described Takotsubo syndrome (TTS) secondary to thyrotoxicosis." | 1.62 | Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. ( Akin, I; Aweimer, A; Borggrefe, M; Dietrich, JW; El-Battrawy, I; Hering, S; Kummer, M; Mügge, A; Patsalis, PC; Stachon, A; Urban, A; Vasileva, S, 2021) |
"Dietary exogenous thyrotoxicosis is infrequently observed in pet food." | 1.62 | Pet Food-Associated Dietary Exogenous Thyrotoxicosis: Retrospective Study (2016-2018) and Clinical Considerations. ( Buchweitz, J; Burkholder, W; Carey, L; Ceric, O; Edwards, E; Glover, M; Heitkemper, D; Hodges, A; Jones, JL; Kemppainen, RJ; Lambkin, S; Lovell, R; Nemser, S; Palmer, LA; Post, L; Refsal, KR; Reimschuessel, R; Rotstein, D; Wilkinson, C; Wilson, R; Wolf, K; Yanes, EG, 2021) |
"Triiodothyronine (T3) was markedly raised with normal TSH receptor antibodies, and the patient later confessed to supplementary testosterone and T3 use as part of bodybuilding activities." | 1.56 | Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsis. ( Pal, A; Warner, BE; Woodrow, CJ, 2020) |
"Onset of thyrotoxicosis was distributed from 2 to 12 months postpartum." | 1.40 | Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. ( Amino, N; Ide, A; Ito, M; Kang, S; Kudo, T; Miyauchi, A; Nakamura, H; Nishihara, E; Yoshioka, W, 2014) |
"Calpain activity was lower in the HT + αT group than in HT and Control + αT and superoxide dismutase (SOD) activity was higher in the HT + αT group than in the Control + αT." | 1.40 | Reactive oxygen species play a role in muscle wasting during thyrotoxicosis. ( Armani, A; Bernardes, SS; Cecchini, AL; Cecchini, R; Guarnier, FA; Marinello, PC; Simão, AN, 2014) |
"Overt hypothyroidism was found in 1." | 1.39 | Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex. ( Detsi, S; Legakis, I; Manousaki, M; Nikita, D, 2013) |
"Exogenous thyrotoxicosis is usually caused by ingestion of excessive amounts of thyroid hormone, which could be intentional or surreptitious (known as factitious thyrotoxicosis)." | 1.38 | Intermittent and recurrent episodes of subclinical hypothyroidism, central hypothyroidism and T3-toxicosis in an elderly woman. ( Díez, JJ; Iglesias, P; Megías, MC; Villanueva, MG, 2012) |
"Although overt thyrotoxicosis is associated with reduced insulin sensitivity (IS), the effects of subclinical thyrotoxicosis (SCTox) (i." | 1.37 | The association of insulin resistance with subclinical thyrotoxicosis. ( Alberto, M; Brenta, G; Niepomniszcze, H; Pusiol, E; Rezzonico, J; Rezzonico, M, 2011) |
"Thymic hyperplasia is associated with Graves' disease, particularly in young patients." | 1.36 | Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. ( Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA, 2010) |
"The pleural effusions were transudates." | 1.36 | Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis. ( Fujita, H; Furumoto, Y; Inoshita, S; Kaneko, S; Kinoshita, H; Maruyama, Y; Suenaga, M; Susa, K; Tomiyama, J; Usui, R; Yakushiji, F; Yasuda, M, 2010) |
"Painless thyroiditis is characterized by transient thyrotoxicosis with complete recovery." | 1.35 | Clinical characteristics of frequently recurring painless thyroiditis: contributions of higher thyroid hormone levels, younger onset, male gender, presence of thyroid autoantibody and absence of goiter to repeated recurrence. ( Isozaki, O; Nishimaki, M; Okubo, Y; Takano, K; Yoshihara, A, 2009) |
"Melatonin treatment suppresses the hyperthyroidism-induced oxidative damage as well as TNF-alpha response." | 1.35 | The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link? ( Akyildiz, M; Icoz, G; Makay, B; Makay, O; Ozgen, G; Unsal, E; Yenisey, C; Yetkin, E, 2009) |
"We report a patient with Graves' disease who developed myalgias with elevated creatine kinase levels after total thyroidectomy." | 1.35 | Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome? ( Kim, CS; Shaheen, D, 2009) |
"McCune-Albright syndrome (MAS) is caused by mutations in GNAS (most often R201C or R201H) leading to constitutive cAMP signaling and multiple endocrine dysfunctions, including morphological and functional thyroid involvement." | 1.35 | The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome. ( Brillante, BA; Celi, FS; Cherman, N; Chidakel, A; Collins, MT; Coppotelli, G; Feuillan, PP; Kelly, M; Shawker, T, 2008) |
"To analyze occurrence of thyroid dysfunction due to regular long-term intake of amiodaron (for one year), to search for predictors of amiodaron-induced hypothyroidism and thyrotoxicosis." | 1.33 | [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron]. ( Bakalov, SA; Golitsyn, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
"Post-partum thyrotoxicosis due to Graves' disease may be treated with radioiodine but it requires radiation safety measurements for infant and is contraindicated if the mother is breast-feeding." | 1.33 | Treatment of post-partum thyrotoxicosis. ( Azizi, F, 2006) |
"Thyrotoxicosis is frequently associated with increased bone turnover and decreased bone mass." | 1.32 | Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1. ( Bianco, AC; Brent, GA; Freitas, FR; Gouveia, CH; Jorgetti, V; Moriscot, AS; Passarelli, M; Scanlan, TS; Soares, AG, 2003) |
"Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 1.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
"400 consecutive patients (300 with Graves' disease and 100 with silent thyroiditis) who underwent radioiodine scanning of the thyroid." | 1.31 | Association between lithium use and thyrotoxicosis caused by silent thyroiditis. ( Daniels, GH; Miller, KK, 2001) |
"Sixty-seven patients with molar pregnancy were studied on admission to Rajvithi Hospital from 1992 to 1996." | 1.30 | Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole. ( Kanchanawat, S; Ngowngarmratana, S; Sunthornthepvarakul, T, 1997) |
"We report a girl with McCune-Albright syndrome who presented with Cushing syndrome from adrenal hypersecretion and gonadotrophin-independent precocious puberty in the first year of life." | 1.30 | Occult T3 toxicosis in McCune-Albright syndrome. ( Brogan, P; Khadilkar, VV; Stanhope, R, 1998) |
"295 patients of Graves' disease were studied for early development of transient hypothyroidism (TH) and its prognostic value following I131 therapy." | 1.30 | Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis. ( Gera, A; Khanna, CM; Magdum, M; Sankar, R, 1998) |
"A maternal history of Graves' disease places the fetus at risk for thyrotoxicosis in utero via the placental transfer of thyroid-stimulating immunoglobulins." | 1.29 | Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. ( Couch, R; Ginsberg, J; Wallace, C, 1995) |
"Clinical thyrotoxicosis is caused by circulating hCG with higher biological activity in pregnant women with hyperemesis." | 1.29 | Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. ( Amino, N; Ito, E; Kimura, M; Mitsuda, N; Miyai, K; Tamaki, H; Tanizawa, O, 1993) |
"The diagnosis of toxic Graves' disease with thyroid hemiagenesis was, therefore, made." | 1.28 | Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements. ( Dickstein, G; Kraiem, Z; Shechner, C; Zuckerman, E, 1992) |
"Isoniazid acetylation was assessed in 10 thyrotoxic patients before and after standard antithyroid therapy." | 1.27 | The effect of thyrotoxicosis on isoniazid acetylation. ( Hutchings, A; Lazarus, JH; Littley, MD; Routledge, PA; Spragg, BP, 1988) |
"Freeze-fracture methods were used to study the sarcoplasmic reticulum and surface membranes in muscles from rats after chronic administration of triiodothyronine (150 micrograms/kg daily, for 1 to 20 days)." | 1.27 | A freeze-fracture study of extensor digitorum longus and soleus muscle fibers from thyrotoxic rats. ( Dulhunty, AF, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (16.60) | 18.7374 |
1990's | 72 (29.88) | 18.2507 |
2000's | 71 (29.46) | 29.6817 |
2010's | 44 (18.26) | 24.3611 |
2020's | 14 (5.81) | 2.80 |
Authors | Studies |
---|---|
Araruna, LVM | 1 |
de Oliveira, DC | 1 |
Pereira, MC | 1 |
Moura Neto, A | 1 |
Tambascia, MA | 1 |
Zantut-Wittmann, DE | 1 |
Varsavsky, M | 1 |
Ortiz, MI | 1 |
Lovazzano, S | 1 |
Scheinfeld, G | 1 |
Cristabel Rubino, G | 1 |
Kozak, A | 1 |
Persani, L | 2 |
dell'Acqua, M | 1 |
Ioakim, S | 1 |
Campi, I | 2 |
Lin, Y | 1 |
Riek, AE | 1 |
Gronowski, AM | 1 |
Farnsworth, CW | 1 |
Suzuki, R | 2 |
Suzuki, S | 1 |
Perego, GB | 1 |
Ravogli, A | 1 |
Groppelli, A | 1 |
Parati, G | 1 |
Fugazzola, L | 1 |
Warner, BE | 1 |
Woodrow, CJ | 1 |
Pal, A | 1 |
Iijima, S | 1 |
Aweimer, A | 1 |
El-Battrawy, I | 1 |
Akin, I | 1 |
Borggrefe, M | 1 |
Mügge, A | 1 |
Patsalis, PC | 1 |
Urban, A | 1 |
Kummer, M | 1 |
Vasileva, S | 1 |
Stachon, A | 1 |
Hering, S | 1 |
Dietrich, JW | 1 |
Tura Bahadır, Ç | 1 |
Yılmaz, M | 1 |
Kılıçkan, E | 1 |
Gao, HT | 1 |
Lasoff, D | 1 |
Minns, A | 1 |
Rotstein, D | 1 |
Jones, JL | 1 |
Buchweitz, J | 1 |
Refsal, KR | 1 |
Wilson, R | 1 |
Yanes, EG | 1 |
Heitkemper, D | 1 |
Edwards, E | 1 |
Post, L | 1 |
Palmer, LA | 1 |
Carey, L | 1 |
Wolf, K | 1 |
Burkholder, W | 1 |
Ceric, O | 1 |
Glover, M | 1 |
Hodges, A | 1 |
Kemppainen, RJ | 1 |
Lambkin, S | 1 |
Lovell, R | 1 |
Nemser, S | 1 |
Wilkinson, C | 1 |
Reimschuessel, R | 1 |
Assimakopoulos, SF | 1 |
Markantes, GK | 1 |
Papageorgiou, D | 1 |
Mamali, I | 1 |
Markou, KB | 2 |
Marangos, M | 1 |
Michalaki, MA | 1 |
Okazaki-Hada, M | 1 |
Maruoka, A | 1 |
Yamamoto, M | 1 |
Ito, M | 3 |
Hirokawa, M | 1 |
Nishikawa, M | 3 |
Akamizu, T | 1 |
Miyauchi, A | 6 |
Toyoda, N | 2 |
Gürkan, E | 1 |
Dolapçıoğlu, K | 1 |
Dirican, E | 1 |
Shah, KK | 1 |
Mbughuni, MM | 1 |
Burgstaler, EA | 1 |
Block, DR | 1 |
Winters, JL | 1 |
Yamauchi, I | 1 |
Sakane, Y | 1 |
Fukuda, Y | 1 |
Fujii, T | 1 |
Taura, D | 1 |
Hirata, M | 1 |
Hirota, K | 1 |
Ueda, Y | 1 |
Kanai, Y | 1 |
Yamashita, Y | 1 |
Kondo, E | 1 |
Sone, M | 1 |
Yasoda, A | 1 |
Inagaki, N | 1 |
Canepa, C | 1 |
Srinivasan, R | 1 |
Muhith, A | 1 |
Bonelli, N | 1 |
Rossetto, R | 1 |
Castagno, D | 1 |
Anselmino, M | 1 |
Vignolo, F | 1 |
Parasiliti Caprino, M | 1 |
Gaita, F | 1 |
Ghigo, E | 1 |
Garberoglio, R | 1 |
Grimaldi, R | 1 |
Maccario, M | 1 |
Yamato, M | 1 |
Wada, K | 1 |
Hayashi, T | 1 |
Fujimoto, M | 1 |
Hosomi, K | 1 |
Oita, A | 1 |
Takada, M | 1 |
Honda, A | 1 |
Uchida, T | 1 |
Komiya, K | 1 |
Goto, H | 1 |
Takeno, K | 1 |
Sato, J | 1 |
Himuro, M | 1 |
Watada, H | 1 |
Pan, Z | 1 |
Cui, T | 1 |
Chen, W | 1 |
Gao, S | 1 |
Pearce, EN | 3 |
Wang, W | 1 |
Chen, Y | 1 |
Guo, W | 1 |
Tan, L | 1 |
Shen, J | 1 |
Zhang, W | 1 |
Hisakado, M | 1 |
Yoshioka, W | 2 |
Kudo, T | 2 |
Nishihara, E | 2 |
Kihara, M | 1 |
Ito, Y | 3 |
Miya, A | 2 |
Fukata, S | 1 |
Nakamura, H | 2 |
Yao, Y | 1 |
Fan, L | 1 |
Zhang, X | 1 |
Xiao, Z | 1 |
Long, Y | 1 |
Tian, H | 1 |
Legakis, I | 1 |
Manousaki, M | 1 |
Detsi, S | 1 |
Nikita, D | 1 |
Kang, GY | 1 |
Parks, JR | 1 |
Fileta, B | 1 |
Chang, A | 1 |
Abdel-Rahim, MM | 1 |
Burch, HB | 2 |
Bernet, VJ | 2 |
Koulouri, O | 1 |
Gurnell, M | 1 |
Lee, KA | 1 |
Park, TS | 1 |
Baek, HS | 1 |
Jin, HY | 1 |
Carlé, A | 1 |
Knudsen, N | 1 |
Pedersen, IB | 1 |
Perrild, H | 2 |
Ovesen, L | 1 |
Rasmussen, LB | 1 |
Laurberg, P | 1 |
Rozanski, A | 1 |
Takano, AP | 1 |
Kato, PN | 1 |
Soares, AG | 2 |
Lellis-Santos, C | 1 |
Campos, JC | 1 |
Ferreira, JC | 1 |
Barreto-Chaves, ML | 1 |
Moriscot, AS | 2 |
Yamamoto, J | 1 |
Dostmohamed, H | 1 |
Schacter, I | 1 |
Ariano, RE | 1 |
Houston, DS | 1 |
Lewis, B | 1 |
Knoll, C | 1 |
Katz, P | 1 |
Zarychanski, R | 1 |
Ide, A | 1 |
Amino, N | 9 |
Kang, S | 1 |
Warner, JV | 1 |
Morton, AP | 1 |
Hall, AJ | 1 |
Henman, MG | 1 |
Pool, LF | 1 |
Bernardes, SS | 1 |
Guarnier, FA | 1 |
Marinello, PC | 1 |
Armani, A | 1 |
Simão, AN | 1 |
Cecchini, R | 1 |
Cecchini, AL | 1 |
Cardoso, LF | 1 |
Maciel, LM | 1 |
Paula, FJ | 1 |
Yoshihara, A | 2 |
Noh, JY | 1 |
Mukasa, K | 1 |
Suzuki, M | 1 |
Ohye, H | 1 |
Matsumoto, M | 1 |
Kunii, Y | 1 |
Watanabe, N | 1 |
Suzuki, N | 1 |
Kameda, T | 1 |
Sugino, K | 1 |
Ito, K | 3 |
Mammen, JS | 1 |
McGready, J | 1 |
Oxman, R | 1 |
Chia, CW | 1 |
Ladenson, PW | 2 |
Simonsick, EM | 1 |
Argatska, A | 1 |
Nonchev, B | 1 |
Orbetzova, M | 1 |
Pehlivanov, B | 1 |
Cruz Grecco Teixeira, MB | 1 |
Martins, GM | 1 |
Miranda-Rodrigues, M | 1 |
De Araújo, IF | 1 |
Oliveira, R | 1 |
Brum, PC | 1 |
Azevedo Gouveia, CH | 1 |
Różycka-Kosmalska, M | 1 |
Michalak, R | 1 |
Kosmalski, M | 1 |
Ptaszyński, P | 1 |
Wranicz, JK | 1 |
Zieleniewski, W | 1 |
Cygankiewicz, I | 1 |
Seger, CD | 1 |
He, X | 1 |
Braverman, LE | 9 |
Yeh, MW | 1 |
Singh, RJ | 1 |
Rhee, CM | 1 |
Leung, AM | 2 |
Küçükler, FK | 1 |
Şimşek, Y | 1 |
Görkem, Ü | 1 |
Ayçiçek Doğan, B | 1 |
Güler, S | 1 |
Kuryłowicz, A | 1 |
Niewiński, G | 1 |
Kański, A | 1 |
Derlatka, P | 1 |
Czajkowski, K | 1 |
Bednarczuk, T | 1 |
Ambroziak, U | 1 |
Michalaki, M | 1 |
Kyriazopoulou, V | 1 |
Paraskevopoulou, P | 1 |
Vagenakis, AG | 1 |
Danilovic, DL | 1 |
Bloise, W | 1 |
Knobel, M | 1 |
Marui, S | 1 |
Graham, BB | 1 |
Burnham, EL | 1 |
Janssen, JS | 1 |
Janssen, WJ | 1 |
Chou, HK | 1 |
Tsao, YT | 1 |
Lin, SH | 1 |
Matrka, L | 1 |
Steward, D | 1 |
Falciglia, M | 1 |
Nikiforov, Y | 1 |
Nishimaki, M | 1 |
Isozaki, O | 1 |
Okubo, Y | 1 |
Takano, K | 2 |
Makay, B | 1 |
Makay, O | 1 |
Yenisey, C | 1 |
Icoz, G | 1 |
Ozgen, G | 1 |
Unsal, E | 1 |
Akyildiz, M | 1 |
Yetkin, E | 1 |
Albaar, MT | 1 |
Adam, JM | 1 |
Mitchell, AL | 1 |
Pearce, S | 1 |
Ezer, A | 1 |
Caliskan, K | 1 |
Parlakgumus, A | 1 |
Belli, S | 1 |
Kozanoglu, I | 1 |
Yildirim, S | 1 |
Shaheen, D | 1 |
Kim, CS | 1 |
Kreisner, E | 1 |
Lutzky, M | 1 |
Gross, JL | 1 |
Boelaert, K | 1 |
Torlinska, B | 1 |
Holder, RL | 1 |
Franklyn, JA | 2 |
Hacihamdioğlu, B | 1 |
Berberoğlu, M | 1 |
Siklar, Z | 1 |
Savaş Erdeve, S | 1 |
Oçal, G | 1 |
Tutar, E | 1 |
Atalay, S | 1 |
Paghera, B | 1 |
Panarotto, MB | 1 |
Maira, G | 1 |
Magri, GC | 1 |
Bertagna, F | 1 |
Bosio, G | 1 |
Rossini, P | 1 |
De Agostini, A | 1 |
Savelli, G | 1 |
Lucchini, S | 1 |
Giubbini, R | 1 |
Popoveniuc, G | 1 |
Sharma, M | 1 |
Devdhar, M | 1 |
Wexler, JA | 1 |
Carroll, NM | 1 |
Wartofsky, L | 1 |
Burman, KD | 1 |
Kinoshita, H | 1 |
Yasuda, M | 1 |
Kaneko, S | 1 |
Usui, R | 1 |
Inoshita, S | 1 |
Furumoto, Y | 1 |
Maruyama, Y | 1 |
Susa, K | 1 |
Suenaga, M | 1 |
Fujita, H | 1 |
Tomiyama, J | 1 |
Yakushiji, F | 1 |
Calvi, L | 1 |
Daniels, GH | 2 |
Solter, M | 1 |
Posavec, L | 1 |
Solter, D | 1 |
Vargek-Solter, V | 1 |
Rezzonico, J | 1 |
Niepomniszcze, H | 2 |
Rezzonico, M | 1 |
Pusiol, E | 1 |
Alberto, M | 1 |
Brenta, G | 1 |
Masannat, Y | 1 |
Gandhy, R | 1 |
Olajide, O | 1 |
Kheetan, R | 1 |
Yaqub, A | 1 |
Pramyothin, P | 1 |
Malabanan, AO | 1 |
Mete, O | 1 |
Asa, SL | 1 |
Megías, MC | 1 |
Iglesias, P | 1 |
Villanueva, MG | 1 |
Díez, JJ | 1 |
Groom, K | 1 |
Snowise, S | 1 |
Wheeler, B | 1 |
Mekhail, A | 1 |
Farrand, S | 1 |
Parry, E | 1 |
Bogazzi, F | 5 |
Bartalena, L | 5 |
Cosci, C | 1 |
Brogioni, S | 3 |
Dell'Unto, E | 2 |
Grasso, L | 3 |
Aghini-Lombardi, F | 4 |
Rossi, G | 2 |
Pinchera, A | 3 |
Martino, E | 9 |
Nyström, E | 1 |
Strachan, MW | 1 |
Walker, JD | 1 |
Patrick, AW | 1 |
Azizi, F | 5 |
Rachmatullov, FK | 1 |
Bondarenko, LA | 1 |
Bibarsova, AM | 1 |
Kapelovich, VIu | 1 |
Osipova, VV | 1 |
Karakina, AN | 1 |
Zinov'eva, EG | 1 |
Tatarchenko, IP | 1 |
Freitas, FR | 1 |
Jorgetti, V | 1 |
Passarelli, M | 1 |
Scanlan, TS | 1 |
Brent, GA | 1 |
Bianco, AC | 1 |
Gouveia, CH | 1 |
CARR, EA | 1 |
BEIERWALTES, WH | 1 |
SPAFFORD, NR | 1 |
DOORENBOS, H | 1 |
BAKKER, A | 1 |
WOLDRING, MG | 1 |
HILTON, JG | 1 |
BLACK, WC | 1 |
ATHOS, W | 1 |
McHUGH, B | 1 |
WESTERMANN, CD | 1 |
GILBERT-DREYFUS, M | 1 |
THOMAS, ID | 1 |
HALES, IB | 1 |
REEVE, TS | 1 |
AROSENIUS, KE | 1 |
SAXENA, KM | 1 |
MARTINO, JA | 1 |
Nascif, SO | 1 |
Senger, MH | 1 |
Ramos-Dias, JC | 1 |
Lengyel, AM | 1 |
Ishii, S | 2 |
Kamegai, J | 2 |
Tamura, H | 1 |
Shimizu, T | 1 |
Sugihara, H | 1 |
Oikawa, S | 1 |
Botella de Maglia, J | 1 |
Compte Torrero, L | 1 |
Rivas Sánchez, A | 1 |
Pérez Pastor, JL | 1 |
Bahrainian, M | 2 |
Khamseh, ME | 1 |
Khoshniat, M | 2 |
Kolawole, BA | 1 |
Ikem, RT | 1 |
Guglielmi, R | 2 |
Pacella, CM | 2 |
Bianchini, A | 1 |
Bizzarri, G | 1 |
Rinaldi, R | 2 |
Graziano, FM | 1 |
Petrucci, L | 1 |
Toscano, V | 1 |
Palma, E | 1 |
Poggi, M | 1 |
Papini, E | 2 |
Erem, C | 1 |
Kandemir, N | 1 |
Hacihasanoglu, A | 1 |
Ersöz, HO | 1 |
Ukinc, K | 1 |
Kocak, M | 1 |
Molashenko, NV | 2 |
Sviridenko, NIu | 2 |
Platonova, NM | 2 |
Kolesnikova, GS | 1 |
Golitsyn, SP | 2 |
Bakalov, SA | 2 |
Serdiuk, SE | 2 |
Masenko, VP | 1 |
Domogadskiĭ, SP | 1 |
Cooper, DS | 2 |
Navaneethakrishnan, R | 1 |
Lindow, SW | 1 |
Masson, EA | 1 |
Allan, B | 1 |
Papi, G | 3 |
Betterle, C | 1 |
Roti, E | 2 |
Minelli, R | 2 |
Valli, MA | 1 |
Di Seclì, C | 1 |
Finardi, L | 1 |
Chiodera, P | 2 |
Bertoni, R | 1 |
Ferrari, C | 1 |
Barilli, AL | 1 |
Coiro, V | 2 |
Saccani Jotti, G | 1 |
Delsignore, R | 1 |
Czarkowski, M | 1 |
Hilgertner, L | 1 |
Powałowski, T | 1 |
Radomski, D | 1 |
Mikulska, M | 1 |
Tran, HA | 1 |
Slyper, AH | 1 |
Wyatt, D | 1 |
Boudreau, C | 1 |
Yoshimura Noh, J | 1 |
Momotani, N | 1 |
Fukada, S | 1 |
Trifănescu, R | 1 |
Fica, S | 1 |
Barbu, C | 1 |
Vârtej, I | 1 |
Ursu, H | 1 |
Bunghez, R | 1 |
Coculescu, M | 1 |
O'Sullivan, AJ | 1 |
Lewis, M | 1 |
Diamond, T | 1 |
Konuma, T | 1 |
Tomonari, A | 1 |
Takahashi, S | 1 |
Ooi, J | 1 |
Tsukada, N | 1 |
Yamada, T | 2 |
Sato, H | 1 |
Nagayama, H | 1 |
Iseki, T | 1 |
Tojo, A | 1 |
Asano, S | 1 |
Iwatani, Y | 1 |
Wang, S | 2 |
Sato, K | 4 |
Shiga, T | 2 |
Matsuda, N | 2 |
Onoda, N | 1 |
Hagiwara, N | 1 |
Kasanuki, H | 2 |
Takano, T | 2 |
Pishdad, GR | 1 |
Pishdad, P | 1 |
Sabzi, A | 1 |
Berti, P | 1 |
Materazzi, G | 1 |
Ambrosini, CE | 1 |
Miccoli, P | 1 |
Tomisti, L | 1 |
Tanda, ML | 1 |
Chung, YJ | 1 |
Lee, BW | 1 |
Kim, JY | 1 |
Jung, JH | 1 |
Min, YK | 1 |
Lee, MS | 1 |
Lee, MK | 1 |
Kim, KW | 1 |
Chung, JH | 1 |
Grabczewska, Z | 1 |
Białoszyński, T | 1 |
Kubica, J | 1 |
Loy, M | 1 |
Perra, E | 1 |
Melis, A | 1 |
Cianchetti, ME | 1 |
Piga, M | 1 |
Serra, A | 1 |
Pinna, G | 1 |
Mariotti, S | 2 |
Tagami, T | 1 |
Hagiwara, H | 1 |
Kimura, T | 1 |
Usui, T | 1 |
Shimatsu, A | 1 |
Naruse, M | 1 |
Bucerius, J | 1 |
Ezziddin, S | 1 |
Brockmann, H | 1 |
Palmedo, H | 1 |
Biersack, HJ | 1 |
Azezli, AD | 1 |
Bayraktaroglu, T | 1 |
Orhan, Y | 1 |
Soule, JB | 1 |
Celi, FS | 1 |
Coppotelli, G | 1 |
Chidakel, A | 1 |
Kelly, M | 1 |
Brillante, BA | 1 |
Shawker, T | 1 |
Cherman, N | 1 |
Feuillan, PP | 1 |
Collins, MT | 1 |
Takamura, Y | 1 |
Kobayashi, K | 1 |
Matsuzuka, F | 1 |
Nomura, E | 1 |
Hsieh, TY | 1 |
Hsu, KF | 1 |
Kuo, PL | 1 |
Huang, SC | 1 |
Freedman, M | 1 |
Sala, M | 1 |
Faraj, G | 1 |
Skowsky, WR | 1 |
Monzani, F | 2 |
Del Guerra, P | 1 |
Caraccio, N | 2 |
Casolaro, A | 1 |
Pucci, E | 1 |
Franchi, F | 1 |
Davison, ET | 1 |
Davison, MJ | 1 |
Wallace, C | 1 |
Couch, R | 1 |
Ginsberg, J | 1 |
Taimela, E | 1 |
Koskinen, P | 1 |
Nuutila, P | 1 |
Nikkanen, V | 1 |
Saraste, M | 1 |
Taimela, S | 1 |
Irjala, K | 1 |
Celik, I | 1 |
Akalin, S | 1 |
Erbaş, T | 1 |
Hidaka, Y | 2 |
Nishi, I | 1 |
Tamaki, H | 3 |
Takeoka, K | 2 |
Tada, H | 3 |
Mitsuda, N | 3 |
Khanna, CM | 2 |
Jain, SK | 1 |
Walia, RP | 1 |
Tsuruta, E | 1 |
Kashiwai, T | 2 |
Asahi, K | 1 |
Grüters-Kieslich, A | 1 |
Feldt-Rasmussen, U | 2 |
Grant, D | 1 |
Kayser, L | 1 |
Delange, F | 1 |
Krassas, GE | 1 |
Pontikides, N | 1 |
Kaltsas, T | 1 |
Papadopoulou, P | 1 |
Batrinos, M | 1 |
Varga, F | 1 |
Tarján, G | 1 |
Steczek, K | 1 |
Földes, J | 1 |
Mason, J | 1 |
Southwick, S | 1 |
Yehuda, R | 1 |
Riney, S | 1 |
Bremner, D | 1 |
Johnson, D | 1 |
Lubin, H | 1 |
Blake, D | 1 |
Zhou, G | 1 |
Bergenfelz, A | 1 |
Ahrén, B | 1 |
Johansen, AH | 1 |
Nielsen, BV | 1 |
Fosella, PV | 1 |
Figge, J | 1 |
Leinung, M | 1 |
Goodman, AD | 1 |
Izquierdo, R | 1 |
Mydosh, T | 1 |
Gates, S | 1 |
Line, B | 1 |
Lee, DW | 1 |
McEwan, J | 1 |
Park, C | 1 |
Johnson, JK | 1 |
Root, AW | 1 |
Kimura, M | 1 |
Ito, E | 1 |
Miyai, K | 2 |
Tanizawa, O | 1 |
Mafauzy, M | 1 |
Wan Mohamad, WB | 1 |
Zahary, MK | 1 |
Mustafa, BE | 1 |
Griggs, RC | 1 |
Bender, AN | 1 |
Tawil, R | 1 |
Burelli, A | 1 |
Refetoff, S | 1 |
Marinov, VS | 1 |
Tunca, H | 1 |
Byrne, MM | 1 |
Sunthornthepvarakul, T | 2 |
Weiss, RE | 1 |
Mooney, CT | 1 |
Thoday, KL | 1 |
Doxey, DL | 1 |
Vitti, P | 1 |
Rago, T | 1 |
Taniyama, M | 1 |
Kitamura, K | 1 |
Ban, Y | 1 |
Sugita, E | 1 |
Katagiri, T | 1 |
Ngowngarmratana, S | 1 |
Kanchanawat, S | 1 |
McCune, N | 1 |
Ritchie, K | 1 |
Volpi, R | 1 |
Marchesi, C | 1 |
DeFerri, A | 1 |
Capretti, L | 1 |
Caffarri, G | 1 |
Colla, R | 1 |
Asmah, BJ | 1 |
Wan Nazaimoon, WM | 1 |
Norazmi, K | 1 |
Tan, TT | 1 |
Khalid, BA | 1 |
Yeo, PP | 1 |
Loh, KC | 1 |
Marqusee, E | 1 |
Haden, ST | 1 |
Utiger, RD | 1 |
Goswami, R | 1 |
Tandon, RK | 1 |
Dudha, A | 1 |
Kochupillai, N | 1 |
Brogan, P | 1 |
Khadilkar, VV | 1 |
Stanhope, R | 1 |
Murao, S | 1 |
Yoshinouchi, T | 1 |
Sato, M | 1 |
Ishida, T | 1 |
Takahara, J | 1 |
Diekman, MJ | 1 |
Romijn, JA | 1 |
Endert, E | 1 |
Sauerwein, H | 1 |
Wiersinga, WM | 1 |
Menzaghi, C | 1 |
Balsamo, A | 1 |
Di Paola, R | 1 |
Gallone, G | 1 |
Rossi, C | 1 |
Tassi, V | 1 |
Fonzo, D | 1 |
De Filippis, V | 1 |
Dottorini, ME | 1 |
Bizzarri, GC | 1 |
Todino, V | 1 |
Crescenzi, A | 1 |
Panunzi, C | 1 |
Rossi, Z | 1 |
Colombo, L | 1 |
Babini, G | 1 |
Gurioli, L | 1 |
Rizzi, R | 1 |
Bertello, P | 1 |
Miyakawa, M | 1 |
Eto, M | 1 |
Inaba, T | 1 |
Ohnishi, S | 1 |
Simkin, PH | 1 |
Ramirez, LA | 1 |
Zweizig, SL | 1 |
Afonso, SA | 1 |
Fraire, AE | 1 |
Khan, A | 1 |
Dunn, AD | 1 |
Dunn, JT | 1 |
Alagöl, F | 1 |
Tanakol, R | 1 |
Boztepe, H | 1 |
Kapran, Y | 1 |
Terzioglu, T | 1 |
Dizdaroglu, F | 1 |
Konrády, A | 1 |
Tollin, SR | 1 |
Fallon, EF | 1 |
Mikhail, M | 1 |
Goldstein, H | 1 |
Yung, E | 1 |
Hedayati, M | 1 |
Al-Abadi, AC | 1 |
Pachucki, J | 1 |
Hopkins, J | 1 |
Peeters, R | 1 |
Tu, H | 1 |
Carvalho, SD | 1 |
Kaulbach, H | 1 |
Abel, ED | 1 |
Wondisford, FE | 1 |
Ingwall, JS | 1 |
Larsen, PR | 1 |
Kasayama, S | 1 |
Miyake, S | 1 |
Samejima, Y | 1 |
Sankar, R | 1 |
Magdum, M | 1 |
Gera, A | 1 |
Solomon, BL | 1 |
Ferguson, P | 1 |
Walpert, N | 1 |
Howard, R | 1 |
Talbot, JA | 1 |
Lambert, A | 1 |
Anobile, CJ | 1 |
McLoughlin, JD | 1 |
Price, A | 1 |
Weetman, AP | 1 |
Robertson, WR | 1 |
Feldkamp, J | 1 |
Pascher, E | 1 |
Schott, M | 1 |
Goretzki, P | 1 |
Seissler, J | 1 |
Scherbaum, WA | 1 |
Yeo, CP | 1 |
Khoo, DH | 1 |
Eng, PH | 1 |
Tan, HK | 1 |
Yo, SL | 1 |
Jacob, E | 1 |
Miller, KK | 1 |
Dahlen, R | 1 |
Osman, F | 1 |
Sheppard, MC | 1 |
Gammage, MD | 1 |
Izumi, Y | 1 |
Tatsumi, KI | 1 |
Ichihara, K | 1 |
Gardini, E | 1 |
Bianconi, L | 1 |
Salvi, M | 1 |
Ikeda, T | 2 |
Ochi, H | 1 |
Ohtani, I | 1 |
Fujiyama, K | 1 |
Hoshino, T | 1 |
Tanaka, Y | 1 |
Takeuchi, T | 1 |
Mashiba, H | 2 |
Scrimshaw, BJ | 1 |
Fellowes, AP | 1 |
Palmer, BN | 1 |
Croxson, MS | 1 |
Stockigt, JR | 1 |
George, PM | 1 |
Shechner, C | 1 |
Kraiem, Z | 1 |
Zuckerman, E | 1 |
Dickstein, G | 1 |
Okamura, K | 1 |
Ikenoue, H | 1 |
Osato, S | 1 |
Tokuyama, T | 1 |
Yoshinari, M | 1 |
Kuroda, T | 1 |
Fujishima, M | 1 |
DelGuerra, P | 1 |
Simoncini, M | 1 |
Giagulli, VA | 1 |
Vermeulen, A | 1 |
Chan, A | 1 |
Shinde, R | 1 |
Chow, CC | 1 |
Cockram, CS | 2 |
Swaminathan, R | 2 |
Tachi, J | 1 |
Gaines-Das, RE | 1 |
Brettschneider, H | 1 |
Bristow, AF | 1 |
Sakata, S | 1 |
Ogawa, T | 1 |
Saulko, AM | 1 |
Tatsievskiĭ, VA | 1 |
Pavliutenkov, MG | 1 |
O'Hare, J | 1 |
Abuaisha, B | 1 |
Barrett, E | 1 |
Hollingsworth, HM | 1 |
Pratter, MR | 1 |
Dubois, JM | 1 |
Irwin, RS | 1 |
Sylvia Vela, B | 1 |
Dorin, RI | 1 |
Sobel, R | 1 |
Bitton, RN | 1 |
Wexler, C | 1 |
Lambert, M | 1 |
Unger, J | 1 |
De Nayer, P | 2 |
Brohet, C | 1 |
Gangji, D | 1 |
Słowiński, S | 1 |
Moszczyński, P | 1 |
Zabówka, M | 1 |
Hosojima, H | 1 |
Miyauchi, E | 1 |
Okada, H | 1 |
Morimoto, S | 1 |
Simons, RJ | 1 |
Manni, A | 1 |
Fang, SL | 1 |
Braverman, L | 1 |
Small, M | 1 |
Buchanan, L | 1 |
Evans, R | 1 |
Milner, MR | 1 |
Gelman, KM | 1 |
Phillips, RA | 1 |
Fuster, V | 1 |
Davies, TF | 1 |
Goldman, ME | 1 |
Ralston, SH | 1 |
Fraser, WD | 1 |
Soukop, M | 1 |
McKillop, JH | 1 |
Littley, MD | 1 |
Hutchings, A | 1 |
Spragg, BP | 1 |
Routledge, PA | 1 |
Lazarus, JH | 1 |
Tucker, WS | 1 |
Liggett, SB | 1 |
Shah, SD | 1 |
Cryer, PE | 1 |
Nakanishi, T | 2 |
Ishizuki, Y | 1 |
Yamauchi, K | 1 |
Miura, Y | 1 |
Friis, J | 1 |
Gelfand, RA | 1 |
Hutchinson-Williams, KA | 1 |
Bonde, AA | 1 |
Castellino, P | 1 |
Sherwin, RS | 1 |
Gauna, A | 1 |
Gajst, O | 1 |
de Felice, MC | 1 |
Guillén, C | 1 |
Sartorio, G | 1 |
Viale, F | 1 |
Gladstein, J | 1 |
Soto, RJ | 1 |
Mulligan, GP | 1 |
Davidson, JS | 1 |
Kaplan, H | 1 |
Abrahamson, MJ | 1 |
Ando, K | 1 |
Saito, K | 1 |
Yamamoto, K | 1 |
Kuzuya, T | 1 |
Mokuda, O | 1 |
Tominaga, M | 1 |
Daughaday, WH | 1 |
Mandel, SH | 1 |
Hanna, CE | 1 |
LaFranchi, SH | 1 |
Avalos, E | 1 |
Beckers, C | 1 |
Péter, F | 1 |
Vermiglio, F | 1 |
Benvenga, S | 1 |
Granata, A | 1 |
Sobbrio, G | 1 |
Melluso, C | 1 |
Carerj, S | 1 |
Arrigo, F | 1 |
Consolo, F | 1 |
Trimarchi, F | 1 |
Lao, TT | 1 |
Chin, RK | 1 |
Panesar, NS | 1 |
Röjdmark, S | 1 |
Berg, A | 1 |
Kallner, G | 1 |
Tynkkynen, P | 1 |
Korhonen, T | 1 |
Välimäki, M | 1 |
Lamberg, BA | 1 |
Lipworth, BJ | 1 |
Dhillon, DP | 1 |
Clark, RA | 1 |
Newton, RW | 1 |
Sestoft, L | 1 |
Saltin, B | 1 |
Date, J | 1 |
Blichert-Toft, M | 1 |
Haas, V | 1 |
Balzano, S | 1 |
Sau, F | 1 |
Ruscazio, M | 1 |
Balestrieri, A | 1 |
Cherchi, A | 1 |
Binimelis, J | 1 |
Bassas, L | 1 |
Marruecos, L | 1 |
Rodriguez, J | 1 |
Domingo, ML | 1 |
Madoz, P | 1 |
Armengol, S | 1 |
Mangues, MA | 1 |
de Leiva, A | 1 |
Dulhunty, AF | 2 |
Gage, PW | 1 |
Lamb, GD | 1 |
Bambini, G | 1 |
Rosner, W | 1 |
Khan, MS | 1 |
Safran, M | 1 |
Sakiyama, R | 1 |
Mechlis, S | 1 |
Lubin, E | 1 |
Laor, J | 1 |
Margaliot, M | 1 |
Strasberg, B | 1 |
Goolden, AW | 1 |
Gartside, JM | 1 |
Osorio, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Development of Rational and Standardized Diagnostics and Staging for a Differentiated Risk Stratification of Non-thyroidal Illness Syndrome[NCT00591032] | 590 participants (Actual) | Observational | 2007-05-31 | Active, not recruiting | |||
Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation[NCT04392258] | 200 participants (Anticipated) | Observational | 2021-05-01 | Recruiting | |||
Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Syncopation and Seizure (Thyro-Syncope)[NCT04879147] | 350 participants (Anticipated) | Observational | 2021-05-05 | Recruiting | |||
Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women[NCT04492657] | 600 participants (Anticipated) | Observational | 2020-01-01 | Recruiting | |||
A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease[NCT02685514] | 22 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
Comparing Virtual Reality Exposure Therapy to Prolonged Exposure in the Treatment of Soldiers With Post Traumatic Stress Disorder (PTSD)[NCT01459705] | 162 participants (Actual) | Interventional | 2011-10-31 | Completed | |||
Comparing Virtual Reality Exposure Therapy to Prolonged Exposure in the Treatment of Soldiers With PTSD[NCT01193725] | 162 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The CAPS is a structured interview that assesses all Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) PTSD criteria in terms of frequency and intensity. We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms. (NCT01459705)
Timeframe: Screening Visit (Day 1)
Intervention | units on scale (Mean) |
---|---|
Prolonged Exposure Therapy (PE) | 78.28 |
Virtual Reality Exposure Therapy (VRET) | 80.44 |
Waitlist | 78.89 |
The CAPS is a structured interview that assesses all DSM-IV PTSD criteria in terms of frequency and intensity. Scores are computed for Intrusion, Avoidance and Hyperarousal symptom clusters, as well as a Total score.We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms. (NCT01459705)
Timeframe: 12 week follow up
Intervention | units on a scale (Mean) |
---|---|
Prolonged Exposure Therapy (PE) | 36.63 |
Virtual Reality Exposure Therapy (VRET) | 55.88 |
The CAPS is a structured interview that assesses all DSM-IV PTSD criteria in terms of frequency and intensity. Scores are computed for Intrusion, Avoidance and Hyperarousal symptom clusters, as well as a Total score.We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms. (NCT01459705)
Timeframe: 2.5 weeks (or after treatment session 5)
Intervention | units on a scale (Mean) |
---|---|
Prolonged Exposure Therapy (PE) | 65.03 |
Virtual Reality Exposure Therapy (VRET) | 71.19 |
Waitlist | 74.73 |
The CAPS is a structured interview that assesses all DSM-IV PTSD criteria in terms of frequency and intensity. Scores are computed for Intrusion, Avoidance and Hyperarousal symptom clusters, as well as a Total score.We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms. (NCT01459705)
Timeframe: 26 Week follow up
Intervention | units on a scale (Mean) |
---|---|
Prolonged Exposure Therapy (PE) | 38.33 |
Virtual Reality Exposure Therapy (VRET) | 54.47 |
The CAPS is a structured interview that assesses all DSM-IV PTSD criteria in terms of frequency and intensity. Scores are computed for Intrusion, Avoidance and Hyperarousal symptom clusters, as well as a Total score.We used total scores as the primary outcome. Minimum possible score was 0, maximum possible score was 136. Higher scores indicated higher levels of symptoms. (NCT01459705)
Timeframe: 5 weeks (or after treatment session 10)
Intervention | units on a scale (Mean) |
---|---|
Prolonged Exposure Therapy (PE) | 44.28 |
Virtual Reality Exposure Therapy (VRET) | 57.07 |
Waitlist | 68.06 |
15 reviews available for triiodothyronine and Thyrotoxicosis
Article | Year |
---|---|
Factitious thyrotoxicosis and thyroid hormone misuse or abuse.
Topics: Humans; Hyperthyroidism; Thyroid Hormones; Thyrotoxicosis; Thyroxine; Triiodothyronine | 2023 |
Povidone-iodine-induced transient triiodothyronine thyrotoxicosis in a Japanese patient with prolonged habitual gargling: A case report and literature review.
Topics: East Asian People; Humans; Hyperthyroidism; Iodine; Male; Middle Aged; Mouthwashes; Povidone-Iodine; | 2023 |
Pitfalls in the assessment of gestational transient thyrotoxicosis.
Topics: Diagnosis, Differential; Female; Humans; Hyperemesis Gravidarum; Pregnancy; Pregnancy Complications; | 2020 |
The multiple effects of thyroid disorders on bone and mineral metabolism.
Topics: Animals; Bone and Bones; Calcification, Physiologic; Calcium; Databases, Bibliographic; Epiphyses; H | 2014 |
[Clinical procedure in amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Risk Factors; Thyroid Diseases; Thyroid | 2016 |
Antithyroid drugs.
Topics: Agranulocytosis; Algorithms; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Me | 2005 |
A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
Topics: Bone and Bones; Cardiovascular System; Humans; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyron | 2005 |
[Current issues in the treatment of thyrotoxicosis].
Topics: Humans; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
[T3 toxicosis].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Diagnosis, Differential; Goiter, Nodular; Graves Di | 2006 |
[T3 toxicosis].
Topics: Humans; Thyrotoxicosis; Triiodothyronine | 1993 |
[Factitious hyperthyroidism and exogenous hyperthyroidism].
Topics: Humans; Hypothyroidism; Thyrotoxicosis; Thyroxine; Triiodothyronine | 1993 |
Subclinical thyrotoxicosis.
Topics: Atrial Fibrillation; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Diagnosis, Different | 1998 |
Subclinical thyrotoxicosis.
Topics: Humans; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 1998 |
Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
Topics: Biopsy; Carcinoma; Fatal Outcome; Female; Goiter, Nodular; Humans; Middle Aged; Propranolol; Thyroid | 1999 |
Subclinical thyrotoxicosis.
Topics: Cardiovascular Diseases; Diagnosis, Differential; Disease Progression; Humans; Hyperthyroidism; Oste | 2001 |
12 trials available for triiodothyronine and Thyrotoxicosis
Article | Year |
---|---|
Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Iodide | 2003 |
Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study.
Topics: Adult; Antithyroid Agents; Breast Feeding; Chi-Square Distribution; Contraindications; Female; Follo | 2003 |
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Hypothyroid | 2005 |
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Female; Follow-U | 2007 |
The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Hyperthyroidis | 2007 |
Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
Topics: Adult; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Interleukin-6; Male; Middle | 1995 |
Comparison of the efficacy of single and multiple regimens of carbimazole in the treatment of thyrotoxicosis.
Topics: Adult; Carbimazole; Drug Administration Schedule; Female; Humans; Male; Thyrotoxicosis; Thyrotropin; | 1993 |
Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Topics: Adult; Antithyroid Agents; Breast Feeding; Female; Humans; Hyperthyroidism; Infant, Newborn; Intelli | 2000 |
The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 2001 |
Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.
Topics: Adult; Apoptosis; Disease Progression; fas Receptor; Female; Graves Disease; Humans; Hyperthyroidism | 2001 |
Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness.
Topics: Adult; Asthma; Asthma, Exercise-Induced; Exercise; Female; Half-Life; Heart Rate; Humans; Male; Meth | 1991 |
Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms.
Topics: Administration, Oral; Adult; Blood Pressure; Diltiazem; Double-Blind Method; Female; Heart Rate; Hum | 1990 |
214 other studies available for triiodothyronine and Thyrotoxicosis
Article | Year |
---|---|
Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Echocardiography; Female; Forced Expiratory | 2021 |
[Factitious hyperthyroidism due to intake of herbal supplements for weight reduction].
Topics: Dietary Supplements; Humans; Hyperthyroidism; Thyrotoxicosis; Thyroxine; Triiodothyronine; Weight Lo | 2022 |
Limited Utility of Free Triiodothyronine Testing.
Topics: Humans; Hyperthyroidism; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 2023 |
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
Topics: Administration, Intravenous; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Hum | 2019 |
Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsis.
Topics: Adult; Athletes; Delayed Diagnosis; Diagnosis, Differential; Humans; Male; Sepsis; Tachycardia; Test | 2020 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study.
Topics: Aged; Female; Homeostasis; Humans; Male; Takotsubo Cardiomyopathy; Thyroid Gland; Thyrotoxicosis; Th | 2021 |
Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Topics: Diagnosis, Differential; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Retrospective Studie | 2021 |
Two Cases of Thyrotoxicosis due to Redotex Ingestion, a Mexican Weight Loss Drug.
Topics: Adult; Atropine; Diazepam; Drug Combinations; Eating; Emodin; Female; Humans; Phenylpropanolamine; T | 2021 |
Pet Food-Associated Dietary Exogenous Thyrotoxicosis: Retrospective Study (2016-2018) and Clinical Considerations.
Topics: Animal Feed; Animals; Diet; Dog Diseases; Dogs; Retrospective Studies; Thyrotoxicosis; Thyroxine; Tr | 2021 |
Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of "non-thyroidal illness syndrome"?
Topics: Aged; Biomarkers; Coronavirus Infections; COVID-19; Euthyroid Sick Syndromes; Female; Ferritins; Hum | 2021 |
Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
Topics: Aged; Biomarkers, Tumor; Goiter, Nodular; Graves Disease; Humans; Iodide Peroxidase; Iodothyronine D | 2021 |
Perinatal effects of maternal FT3/FT4 ratio on gestational transient thyrotoxicosis.
Topics: Case-Control Studies; Female; Humans; Infant; Pregnancy; Thyroid Function Tests; Thyrotoxicosis; Thy | 2021 |
Iatrogenic thyrotoxicosis and the role of therapeutic plasma exchange.
Topics: Animals; Cattle; Female; Humans; Iatrogenic Disease; Middle Aged; Plasma Exchange; Thyroid Hormones; | 2017 |
Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Lung Neoplasm | 2017 |
Reversible and unilateral corticospinal tract disease secondary to autoimmune free-T3-thyrotoxicosis.
Topics: Aged; Female; Humans; Pyramidal Tracts; Spinal Cord Diseases; Thyroiditis, Autoimmune; Thyrotoxicosi | 2017 |
Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status.
Topics: Aged; Contrast Media; Coronary Angiography; Cross-Sectional Studies; Female; Humans; Hyperthyroidism | 2018 |
Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; | 2018 |
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged | 2017 |
Serum iodine concentration in pregnant women and its association with urinary iodine concentration and thyroid function.
Topics: Adult; China; Female; Humans; Iodide Peroxidase; Iodine; Pregnancy; Thyroglobulin; Thyroid Diseases; | 2019 |
Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Topics: Adolescent; Adult; Aged; Appetite; Body Temperature; Cold Temperature; Defecation; Female; Hormone R | 2019 |
Episodes of paralysis in Chinese men with thyrotoxic periodic paralysis are associated with elevated serum testosterone.
Topics: Adult; Asian People; China; Humans; Male; Middle Aged; Paralyses, Familial Periodic; Testosterone; T | 2013 |
Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Autoimmunity; | 2013 |
Thyroxine and triiodothyronine content in commercially available thyroid health supplements.
Topics: Animals; Chromatography, High Pressure Liquid; Consumer Product Safety; Dietary Supplements; Electro | 2013 |
How to interpret thyroid function tests.
Topics: Biomarkers; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Predictive Value of Tests; Sensi | 2013 |
Pituitary apoplexy in T3 thyrotoxicosis.
Topics: Antithyroid Agents; Comorbidity; Humans; Hydrocortisone; Hyperthyroidism; Male; Middle Aged; Neurosu | 2014 |
Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aging; Autoantibodies; Female; Goiter, Nodular; Graves Dise | 2013 |
M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.
Topics: Animals; Animals, Newborn; Base Sequence; Cardiomegaly; Cell Line; Cells, Cultured; Connectin; Down- | 2013 |
Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Component Removal; Female; Humans; Middle Aged; Preoperati | 2014 |
Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Topics: Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Postpartum Period; Receptors, Thy | 2014 |
Internet slimming, thyrotoxicosis and the liver.
Topics: Adult; Appetite Depressants; Chemical and Drug Induced Liver Injury; China; Cyclobutanes; Drug Combi | 2014 |
Reactive oxygen species play a role in muscle wasting during thyrotoxicosis.
Topics: alpha-Tocopherol; Animals; Antioxidants; Body Weight; Calpain; Cytochromes c; Male; Malondialdehyde; | 2014 |
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Topics: Algorithms; Chorionic Gonadotropin; Diagnosis, Differential; Female; Graves Disease; Hashimoto Disea | 2015 |
Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.
Topics: Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Baltimore; Bone Density; Ethnicity; Female; Hea | 2015 |
Postpartum thyroid dysfunction in women with autoimmune thyroiditis.
Topics: Adult; Autoantibodies; Female; Humans; Hypothyroidism; Postpartum Period; Pregnancy; Pregnancy Trime | 2016 |
Lack of α2C-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia.
Topics: Animals; Biomechanical Phenomena; Bone Diseases, Metabolic; Bone Remodeling; Female; Femur; Gene Exp | 2016 |
Negligible Thyroid Hormone Content Present in Nonprescription U.S. Weight Loss Products.
Topics: Animals; Anti-Obesity Agents; Dietary Supplements; Food Contamination; Food Inspection; Food Labelin | 2017 |
Relationship between gestational transient thyrotoxicosis and vitamin D.
Topics: Female; Humans; Pregnancy; Pregnancy Complications; Thyroid Function Tests; Thyrotoxicosis; Thyrotro | 2016 |
Severe gestational hyperthyroidism complicated by cardiac arrest - a case report.
Topics: Abortion, Therapeutic; Adult; Antithyroid Agents; Cardiopulmonary Resuscitation; Female; Heart Arres | 2017 |
The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Topics: Adult; Aged; Aged, 80 and over; Contraindications; Dose-Response Relationship, Drug; Female; Goiter, | 2008 |
Factitious thyrotoxicosis induced by mesotherapy: a case report.
Topics: Adipose Tissue; Adult; Cosmetic Techniques; Female; Humans; Obesity; Thyrotoxicosis; Triiodothyronin | 2008 |
Dyspnea, chest pain, and altered mental status in a 33-year-old carpenter.
Topics: Adult; Chest Pain; Diagnosis, Differential; Dyspnea; Humans; Male; Thyrotoxicosis; Thyroxine; Triiod | 2008 |
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Atrial Fibrillation; Contrast Media; Humans; Iopanoic Acid; Male; Middle Aged; Thyroidec | 2008 |
Clinical characteristics of frequently recurring painless thyroiditis: contributions of higher thyroid hormone levels, younger onset, male gender, presence of thyroid autoantibody and absence of goiter to repeated recurrence.
Topics: Adolescent; Adult; Age of Onset; Autoantibodies; Female; Humans; Male; Middle Aged; Recurrence; Regr | 2009 |
The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link?
Topics: Animals; Antioxidants; Cytokines; Glutathione; Male; Malondialdehyde; Melatonin; Nitrates; Nitrites; | 2009 |
Gestational transient thyrotoxicosis.
Topics: Chorionic Gonadotropin; Diagnosis, Differential; Female; Global Health; Humans; Incidence; Pregnancy | 2009 |
An elderly woman with weight loss and diarrhoea.
Topics: Aged, 80 and over; Diarrhea; Female; Humans; Thyrotoxicosis; Triiodothyronine; Weight Loss | 2009 |
Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.
Topics: Adult; Agranulocytosis; Antithyroid Agents; Female; Humans; Male; Middle Aged; Plasma Exchange; Preo | 2009 |
Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome?
Topics: Creatine Kinase; Female; Graves Disease; Humans; Myositis; Syndrome; Thyroid Hormones; Thyroidectomy | 2009 |
Charcoal hemoperfusion in the treatment of levothyroxine intoxication.
Topics: Charcoal; Drug Compounding; Female; Goiter; Hemoperfusion; Humans; Middle Aged; Thyrotoxicosis; Thyr | 2010 |
Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study.
Topics: Adolescent; Adult; Age Factors; Aged; Cross-Sectional Studies; Female; Goiter, Nodular; Humans; Hype | 2010 |
Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Female; Humans; Male; Thyrotoxicosis; Thyroxi | 2010 |
¹³¹I treatment of toxic nodular goiter under combined thyrostatic-thyromimetic medication is at low risk of late hypothyroidism.
Topics: Adult; Aged; Aged, 80 and over; Antithyroid Agents; Combined Modality Therapy; Female; Goiter, Nodul | 2010 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Bl | 2010 |
Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
Topics: Adult; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Pleural Effusion; Thyroto | 2010 |
Thyroid hormone analogues: ready for prime time.
Topics: Atherosclerosis; Humans; Hypercholesterolemia; Ischemia; Neoplasms; Thyroid Hormones; Thyrotoxicosis | 2011 |
Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.
Topics: Adult; Cardiac Catheterization; Contrast Media; Humans; Ioxaglic Acid; Male; Thyroglobulin; Thyroidi | 2011 |
Increased thyroidal T4 to T3 conversion in autonomously functioning thyroid adenoma: from euthyroidism to thyrotoxicosis.
Topics: Adenoma; Adult; Humans; Middle Aged; Thyroid Gland; Thyroid Neoplasms; Thyrotoxicosis; Thyrotropin; | 2011 |
The association of insulin resistance with subclinical thyrotoxicosis.
Topics: Adolescent; Adult; Analysis of Variance; Argentina; Asymptomatic Diseases; Biomarkers; Blood Glucose | 2011 |
Chorea associated with thyrotoxicosis due to toxic multinodular goiter.
Topics: Antithyroid Agents; Atenolol; Chorea; Dibenzothiazepines; Female; Goiter, Nodular; Humans; Hyperthyr | 2011 |
Clinical problem-solving. A hidden solution.
Topics: Anti-Infective Agents, Local; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Middle | 2011 |
Images in endocrine pathology: thyrotoxicosis associated with destructive thyroiditis.
Topics: Amiodarone; Heart Diseases; Humans; Male; Middle Aged; Thyroidectomy; Thyroiditis; Thyrotoxicosis; T | 2012 |
Intermittent and recurrent episodes of subclinical hypothyroidism, central hypothyroidism and T3-toxicosis in an elderly woman.
Topics: Aged, 80 and over; Animals; Female; Humans; Hypothyroidism; Meat; Recurrence; Swine; Thyroglobulin; | 2012 |
Maternal thyrotoxicosis and fetal goitre requiring in utero therapy for hypothyroidism and subsequent neonatal therapy for hyperthyroidism.
Topics: Antithyroid Agents; Carbimazole; Female; Fetal Diseases; Fetal Therapies; Goiter; Graves Disease; Hu | 2013 |
[Dieting with (un)known hormones].
Topics: Dietary Supplements; Female; Humans; Risk Factors; Thyrotoxicosis; Triiodothyronine; Weight Loss | 2003 |
Severe hypercalcaemia secondary to isolated adrenocorticotrophic hormone deficiency and subacute thyroiditis.
Topics: Adrenocorticotropic Hormone; Diagnosis, Differential; Glucocorticoids; Humans; Hypercalcemia; Male; | 2003 |
[Hemodynamics, electrophysiological parameters of the heart and differential therapy of attacks of atrial fibrillation in patients with subclinical thyroid dysfunction].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Data Interpretation, Statist | 2003 |
Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cholesterol; Female; Femur; Rats; Rats | 2003 |
The uptake of triiodothyronine by erythrocytes in pregnancy complicated by thyrotoxicosis.
Topics: Erythrocytes; Female; Humans; Hyperthyroidism; Pregnancy; Pregnancy Complications; Thyrotoxicosis; T | 1960 |
Red cell triiodothyronine uptake in relation to the result of treatment in thyrotoxicosis and myxedema.
Topics: Erythrocytes; Humans; Hyperthyroidism; Myxedema; Thyroid Function Tests; Thyrotoxicosis; Triiodothyr | 1962 |
Increased ACTH-like activity in plasma of patients with thyrotoxicosis.
Topics: Adrenocorticotropic Hormone; Catecholamines; Humans; Hydrocortisone; Hyperthyroidism; Thyrotoxicosis | 1962 |
[DIAGNOSTIC ABUSES IN BASEDOWIAN THYROTOXICOSIS. FREQUENCY OF BASEDOWIAN THYROSIS IN THE LIGHT OF THE TEST OF INHIBITION BY TRIIODOTHYRONINE].
Topics: Diagnosis; Goiter; Graves Disease; Humans; Thyroid Function Tests; Thyrotoxicosis; Triiodothyronine | 1964 |
THYROTOXICOSIS.
Topics: Antithyroid Agents; Humans; Hyperthyroidism; Iodine Isotopes; Thyroid Function Tests; Thyroidectomy; | 1964 |
THE IODO-AMINO ACIDS IN THE THYROID GLAND IN THYROTOXICOSIS; A STUDY USING ANION-EXCHANGE RESIN AND HIGH-VOLTAGE PAPER ELECTROPHORESIS.
Topics: Adolescent; Amino Acids; Anions; Antithyroid Agents; Diiodotyrosine; Drug Therapy; Electrophoresis, | 1964 |
THYROTOXICOSIS IN CHILDHOOD.
Topics: Child; Congenital Hypothyroidism; Diagnosis; Humans; Hyperthyroidism; Infant; Infant, Newborn; Propy | 1965 |
SIMULTANEOUS OCCURRENCE OF ADDISON'S DISEASE AND THYROTOXICOSIS.
Topics: Addison Disease; Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Basal Metabolism; E | 1965 |
Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Topics: Adolescent; Adult; Antithyroid Agents; Area Under Curve; Female; Fluorescent Antibody Technique; Gro | 2003 |
Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
Topics: Animals; Arginine; Body Weight; Eating; Energy Metabolism; Gastric Mucosa; Gene Expression; Ghrelin; | 2003 |
[Triiodothyronine intoxication. A clinical and phamacokinetic study].
Topics: Absorption; Adult; Biological Availability; Carcinoma, Papillary; Female; Half-Life; Hemoperfusion; | 2003 |
Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole.
Topics: Breast Feeding; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Intelligence; | 2003 |
A study of psychiatric symptoms in thyrotoxic Nigerians.
Topics: Adult; Affective Symptoms; Anxiety Disorders; Case-Control Studies; Cross-Sectional Studies; Depress | 2003 |
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy.
Topics: Administration, Cutaneous; Cost-Benefit Analysis; Cysts; Ethanol; Health Care Costs; Humans; Injecti | 2004 |
Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Goiter, Nodular; Graves Disease; Hu | 2004 |
[The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autoantibodies; Blood Flow Velocity; Elect | 2004 |
Recurrent gestational thyrotoxicosis presenting as recurrent hyperemesis gravidarum--report of two cases.
Topics: Abortion, Spontaneous; Adult; Antithyroid Agents; Carbimazole; Female; Gestational Age; Heart Rate, | 2004 |
Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease?
Topics: Adolescent; Adult; Carotid Artery, Common; Cholesterol; Female; Graves Disease; Humans; Male; Middle | 2005 |
Thyrotoxic periodic paralysis.
Topics: Adult; Diagnosis, Differential; Female; Humans; Hypokalemic Periodic Paralysis; Muscle Weakness; Par | 2005 |
Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; G | 2005 |
Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Male; Sensitivity and Specificity; T | 2005 |
[Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism; Inci | 2005 |
Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2004 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
[Thyroid hormone and various other hormones regulate hypothalamic neuropeptide Y (NPY) expression and feeding behavior].
Topics: Animals; Arginine; Eating; Ghrelin; Hypothalamic Hormones; Hypothalamus; Insulin; Intracellular Sign | 2006 |
Treatment of post-partum thyrotoxicosis.
Topics: Antithyroid Agents; Breast Feeding; Female; Graves Disease; Humans; Infant, Newborn; Iodine Radioiso | 2006 |
Early-onset thyrotoxicosis after unrelated cord blood transplantation for acute myelogenous leukemia.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Cord Blood Stem Cell Transplantation; Female; Humans; Io | 2006 |
Traumatic stress and thyroid function.
Topics: Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Stress Disorders, Post-Traumatic; | 2006 |
Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Autoantibodies; Humans; Immunoglobulins, Thyroid-Stimulati | 2006 |
Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mid | 2006 |
A case of transient central hyperthyroidism.
Topics: Anti-Anxiety Agents; Chronic Disease; Female; Follow-Up Studies; Humans; Hyperthyroidism; Hypothyroi | 2006 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2006 |
[Acute myocardial infarction in a patient with iatrogenic thyrotoxicosis--a case report].
Topics: Adult; Coronary Angiography; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Humans; | 2007 |
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Goiter, Nodular; Graves D | 2007 |
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; | 2007 |
Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Coumarins; Female; Humans; International Normali | 2007 |
Case history: thyrotoxicosis factitia secondary to triiodothyronine acquired electronically from abroad.
Topics: Adult; Commerce; Humans; Internet; Obesity; Thyrotoxicosis; Triiodothyronine | 2007 |
The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Cells, Cultured; Child; Child, Preschool; Ch | 2008 |
3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod | 2008 |
Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cycl | 2008 |
Psychological changes during thyrotoxicosis.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Methimazole; Middle Aged; Personality; Personality Test | 1993 |
Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis.
Topics: Aged; Antithyroid Agents; Female; Hematoma; Humans; Propranolol; Thyroid Diseases; Thyroid Function | 1995 |
Percutaneous ethanol injection therapy of autonomous nodule and amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Ethanol; Humans; Injections, Intradermal; Iodine; Male; Middle Aged; Thyroid Nodule; Thy | 1994 |
Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia.
Topics: Adult; Diagnosis, Differential; Humans; Hypokalemia; Male; Paralyses, Familial Periodic; Tachycardia | 1995 |
Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment.
Topics: Adult; Algorithms; Female; Fetal Diseases; Graves Disease; Heart Rate, Fetal; Humans; Pregnancy; Pre | 1995 |
Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; Drug Monitoring; Female; Humans; Hyperthyroidism; Male; Middle Aged; | 1995 |
Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Immunoradiometric Assay; Puerperal D | 1994 |
Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy.
Topics: Adult; Aged; Antibodies; Carbimazole; Female; Follow-Up Studies; Forecasting; Humans; Hypothyroidism | 1994 |
Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis.
Topics: Adult; Asialoglycoproteins; Chorionic Gonadotropin; Female; Humans; Hyperemesis Gravidarum; Pregnanc | 1995 |
Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study.
Topics: Adolescent; Child; Child, Preschool; Europe; Female; Humans; Male; Pediatrics; Surveys and Questionn | 1994 |
Menstrual disturbances in thyrotoxicosis.
Topics: Adult; Female; Humans; Menstruation Disturbances; Smoking; Thyrotoxicosis; Thyroxine; Triiodothyroni | 1994 |
[Zn-content of erythrocytes in overt and subclinical hyperthyroidism].
Topics: Erythrocytes; Female; Humans; Hyperthyroidism; Spectrophotometry; Thyroid Nodule; Thyrotoxicosis; Th | 1994 |
Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder.
Topics: Adult; Combat Disorders; Comorbidity; Follow-Up Studies; Humans; Hyperthyroidism; Male; Pilot Projec | 1994 |
Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder.
Topics: Adult; Combat Disorders; Comorbidity; Follow-Up Studies; Humans; Hyperthyroidism; Male; Pilot Projec | 1994 |
Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder.
Topics: Adult; Combat Disorders; Comorbidity; Follow-Up Studies; Humans; Hyperthyroidism; Male; Pilot Projec | 1994 |
Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder.
Topics: Adult; Combat Disorders; Comorbidity; Follow-Up Studies; Humans; Hyperthyroidism; Male; Pilot Projec | 1994 |
Hyperthyroxinemia after surgery for primary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cholecystectomy, Laparoscopic; Female; Humans; Hyperparathyroidism; Hyperthyro | 1994 |
[T3 thyrotoxicosis in a patient with a hormonally active, metastasizing follicular thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Female; Humans; Lung Neoplasms; Middle Aged; Thyroid Neoplasms; Thyrotox | 1994 |
Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.
Topics: Aged; Amiodarone; Combined Modality Therapy; Female; Humans; Male; Methimazole; Middle Aged; Plasmap | 1993 |
The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis.
Topics: Adult; Aged; Ambulatory Care; Diagnosis, Differential; Female; Humans; Hyperthyroidism; Male; Middle | 1994 |
Nonvisualization of suppressed thyroid tissue on Tl-201 scintigraphy.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Radionuclide Imaging; Thallium Radioisotopes; Thyroid G | 1993 |
Outcome of treating thyrotoxic patients with a standard dose of radioactive iodine.
Topics: Adult; Aftercare; Aged; Aged, 80 and over; Family Practice; Female; Follow-Up Studies; Humans; Hypot | 1993 |
Free triiodothyronine toxicosis in two adolescents.
Topics: Adolescent; Humans; Male; Thyrotoxicosis; Triiodothyronine | 1994 |
Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity.
Topics: Chorionic Gonadotropin; Female; Humans; Hyperemesis Gravidarum; Pregnancy; Thyroid Gland; Thyrotoxic | 1993 |
A puzzling case of periodic paralysis.
Topics: Adult; Humans; Hypokalemia; Male; Paralyses, Familial Periodic; Thyrotoxicosis; Triiodothyronine | 1996 |
Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants.
Topics: Adult; Antithyroid Agents; Breast Feeding; Dose-Response Relationship, Drug; Drug Administration Sch | 1996 |
Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
Topics: Adult; Aged; Amiodarone; Drug Therapy, Combination; Female; Humans; Interleukin-6; Male; Methimazole | 1996 |
A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
Topics: Adolescent; Adult; Aged; Base Sequence; Diagnosis, Differential; Female; Humans; Hyperthyroxinemia; | 1996 |
Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
Topics: Animals; Cat Diseases; Cats; Cattle; Female; Hyperthyroidism; Hysterectomy; Male; Orchiectomy; Ovari | 1996 |
Color flow Doppler sonography in thyrotoxicosis factitia.
Topics: Adult; Aged; Female; Humans; Middle Aged; Thyroid Gland; Thyroid Hormones; Thyrotoxicosis; Thyrotrop | 1996 |
Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis.
Topics: Adolescent; Adrenomedullin; Adult; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptides; P | 1997 |
Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
Topics: Adolescent; Adult; Chorionic Gonadotropin; Female; Humans; Hydatidiform Mole; Hyperthyroidism; Middl | 1997 |
ADHD/thyroid dysfunction.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Male; Neurocogniti | 1997 |
Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis.
Topics: Adult; Cholinesterase Inhibitors; Depression; Diagnosis, Differential; Humans; Male; Pyridostigmine | 1998 |
Plasma renin and aldosterone in thyroid diseases.
Topics: Aldosterone; Cross-Sectional Studies; Diuretics; Furosemide; Humans; Hypothyroidism; Potassium; Reni | 1997 |
Prevalence and significance of steatorrhea in patients with active Graves' disease.
Topics: Absorption; Adult; Antithyroid Agents; Body Mass Index; Carbimazole; Case-Control Studies; Celiac Di | 1998 |
Occult T3 toxicosis in McCune-Albright syndrome.
Topics: Antithyroid Agents; Carbimazole; Child, Preschool; Female; Fibrous Dysplasia, Polyostotic; Humans; T | 1998 |
Silent thyroiditis after excision of a thymoma.
Topics: Humans; Male; Middle Aged; Postoperative Complications; Propranolol; Thymoma; Thymus Neoplasms; Thyr | 1998 |
Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women.
Topics: Adult; Aged; Body Mass Index; Female; Humans; Hypothyroidism; Leptin; Methimazole; Middle Aged; Mult | 1998 |
Association between an R338L mutation in the thyroid hormone receptor-beta gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone.
Topics: Adolescent; Aged; Alleles; Amino Acid Substitution; Arginine; Female; Follow-Up Studies; Haplotypes; | 1999 |
Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation.
Topics: Adenoma; Biopsy, Needle; Female; Humans; Iodine Radioisotopes; Laser Therapy; Liver; Liver Neoplasms | 1999 |
Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis.
Topics: Alkaline Phosphatase; Antithyroid Agents; Bilirubin; gamma-Glutamyltransferase; Humans; Hyperbilirub | 1999 |
Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Humans; Hypothyroidism; | 1999 |
Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis.
Topics: Aged; Female; Humans; Ovarian Neoplasms; Radionuclide Imaging; Struma Ovarii; Thyroglobulin; Thyroto | 1999 |
[T3-thyrotoxicosis: incidence, significance and correlation with iodine intake].
Topics: Graves Disease; Humans; Hungary; Iodine; Thyrotoxicosis; Thyroxine; Triiodothyronine | 2000 |
The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Humans; Iodine Radioisotopes; Male; Middle A | 2000 |
Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis.
Topics: Adenine Nucleotides; Animals; Calcium-Transporting ATPases; Creatine Kinase; Energy Metabolism; Hear | 2001 |
Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate.
Topics: Antineoplastic Agents, Hormonal; Autoantibodies; Female; Humans; Hypothyroidism; Iodide Peroxidase; | 2000 |
Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Thyrotoxico | 1998 |
The nature of human chorionic gonadotrophin glycoforms in gestational thyrotoxicosis.
Topics: Adult; Chorionic Gonadotropin; Chromatography, Affinity; Chromatography, Liquid; Female; Humans; Hyd | 2001 |
Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin.
Topics: Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Pregnancy; Pregnancy Complications; Pre | 2001 |
Association between lithium use and thyrotoxicosis caused by silent thyroiditis.
Topics: Adult; Antimanic Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Lithium Carbonate; Ma | 2001 |
Managing patients with acute thyrotoxicosis.
Topics: Acute Disease; Administration, Oral; Adult; Antithyroid Agents; Female; Heart Failure; Humans; Potas | 2002 |
Successful treatment of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autoantibodies; Carbimazole; Cohort Studies; Female; Humans; | 2002 |
Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Diagnosis, Differential; Eo | 2002 |
Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Topics: Amiodarone; Antibodies; Humans; Hypothyroidism; Male; Methimazole; Methylprednisolone; Middle Aged; | 1992 |
Adrenergic mechanism in hyperketonemia in thyrotoxic and starved rats.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; | 1992 |
A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding.
Topics: Base Sequence; DNA Probes; Electrophoresis, Agar Gel; Female; Humans; Male; Molecular Sequence Data; | 1992 |
Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Immunor | 1992 |
Thyrotoxicosis with low serum total T3 level in patients with destructive thyroiditis and non-thyroidal illness.
Topics: Adult; Euthyroid Sick Syndromes; Female; Humans; Male; Prevalence; Thyroiditis; Thyrotoxicosis; Trii | 1992 |
Occupational thyroid disease.
Topics: Adult; Beauty Culture; Cosmetics; Female; Humans; Iodine; Occupational Exposure; Thyrotoxicosis; Thy | 1992 |
Increased plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide concentration in clinically euthyroid women with suppressed plasma thyrotropin levels: further evidence for generalized tissue overexposure to thyroid hormones in these subjects.
Topics: Aged; Androstane-3,17-diol; Female; Humans; Reference Values; Sex Hormone-Binding Globulin; Thyroid | 1992 |
In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.
Topics: Adult; Blood Platelets; Humans; Male; Paralysis; Periodicity; Rubidium; Sodium-Potassium-Exchanging | 1991 |
Massage therapy on neck: a contributing factor for destructive thyrotoxicosis?
Topics: Autoantibodies; Female; Humans; Immunoglobulins, Thyroid-Stimulating; Massage; Middle Aged; Neck; Th | 1990 |
The effects of common matrices for assay standards on performance of 'ultra sensitive' immunometric assays for TSH. Report of a joint WHO/IFCC collaborative study.
Topics: Calibration; Humans; Immunoassay; Reagent Kits, Diagnostic; Reference Standards; Thyrotoxicosis; Thy | 1991 |
Free T3 toxicosis: a distinct entity?
Topics: Adolescent; Autoantibodies; Female; Humans; Thyroiditis, Autoimmune; Thyrotoxicosis; Triiodothyronin | 1991 |
[Radioimmunodiagnosis in the correction of plasmapheresis methodology in thyrotoxicosis].
Topics: Heparin; Humans; Plasmapheresis; Premedication; Radioimmunoassay; Thyrotoxicosis; Thyrotropin; Thyro | 1991 |
Audit of hyperthyroxinaemia and thyrotoxicosis using a sensitive TSH assay.
Topics: Humans; Hyperthyroxinemia; Retrospective Studies; Thyrotoxicosis; Thyrotropin; Thyroxine; Thyroxine- | 1991 |
Factitious triiodothyronine toxicosis.
Topics: Adult; Factitious Disorders; Humans; Male; Thyrotoxicosis; Triiodothyronine | 1991 |
Discordant thyroid hormone levels.
Topics: Humans; Thyroid Function Tests; Thyrotoxicosis; Thyroxine; Triiodothyronine | 1991 |
Free triiodothyronine toxicosis: a distinct entity.
Topics: Female; Humans; Middle Aged; Thyrotoxicosis; Thyroxine-Binding Proteins; Triiodothyronine | 1990 |
Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.
Topics: Adult; Amiodarone; Humans; Male; Middle Aged; Thyroglobulin; Thyroid Gland; Thyrotoxicosis; Thyrotro | 1990 |
[Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis].
Topics: Adult; Drug Therapy, Combination; Electrocardiography; Female; Humans; Methimazole; Propranolol; Tac | 1990 |
[Erythrocyte sorbitol levels in patients with thyrotoxicosis].
Topics: Adult; Erythrocytes; Female; Humans; Hyperthyroidism; L-Iditol 2-Dehydrogenase; Male; Sorbitol; Suga | 1990 |
Free triiodothyronine toxicosis in a patient with multinodular goiter.
Topics: Aged; Goiter, Nodular; Humans; Male; Thyrotoxicosis; Triiodothyronine | 1990 |
Value of screening thyroid function in acute medical admissions to hospital.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Diagnostic Tests, Routine; Female; Humans; Hypothyroi | 1990 |
'Apathetic' thyrotoxicosis presenting with hypercalcaemia and spurious normalization of serum thyroid hormone levels.
Topics: Antithyroid Agents; Body Weight; Female; Humans; Hypercalcemia; Middle Aged; Thyroid Hormones; Thyro | 1987 |
The effect of thyrotoxicosis on isoniazid acetylation.
Topics: Acetylation; Adult; Aged; Antithyroid Agents; Female; Half-Life; Humans; Iodine Radioisotopes; Isoni | 1988 |
Euthyroid hyperthyroxinemia due to familial excess of thyroxine-binding globulin.
Topics: Adult; Diagnosis, Differential; Euthyroid Sick Syndromes; Humans; Hyperthyroxinemia; Male; Pedigree; | 1989 |
Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Blood Glucose; Blood Pressure; C-Peptide; Cyclic AMP; | 1989 |
T3-toxicosis and T4-toxicosis in a schizophrenic patient: report on a rare case.
Topics: Adult; Humans; Male; Schizophrenia; Thyrotoxicosis; Thyroxine; Triiodothyronine | 1989 |
[Transient thyrotoxicosis induced by Japanese kombu].
Topics: Adult; Female; Foodborne Diseases; Humans; Iodine; Middle Aged; Seaweed; Thyrotoxicosis; Thyroxine; | 1989 |
The perchlorate discharge test with and without supplement of potassium iodide.
Topics: Adenoma; Administration, Oral; Goiter, Nodular; Humans; Iodine Radioisotopes; Perchlorates; Potassiu | 1987 |
Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Body Weight; Energy Intake; Energy Metabolism | 1987 |
Modifications of serum hepatic enzymes in thyrotoxic patients with and without treatment.
Topics: Adult; Alkaline Phosphatase; Female; gamma-Glutamyltransferase; Humans; Imidazoles; Liver; Middle Ag | 1988 |
Euthyroid hyperthyroxinaemia due to endogenous antibodies to thyroxine and tri-iodothyronine. A case report.
Topics: Autoantibodies; Diagnosis, Differential; Female; Humans; Hyperthyroxinemia; Middle Aged; Thyrotoxico | 1989 |
Endotoxin-induced ATP depletion in thyrotoxic rats.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Dose-Response Relationship, Drug; Endoto | 1986 |
Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine.
Topics: Animals; Arginine; Blood Glucose; Epinephrine; Glucagon; Glucose; Glucose Tolerance Test; Insulin; I | 1988 |
Thyrotoxicosis after thyroidectomy. Iatrogenic or factitious?
Topics: Adult; Female; Humans; Medication Errors; Self Administration; Tachycardia, Paroxysmal; Thyroidectom | 1986 |
Diminished thyroid-stimulating hormone secretion associated with neonatal thyrotoxicosis.
Topics: Diseases in Twins; Humans; Infant, Newborn; Male; Propylthiouracil; Thyrotoxicosis; Thyrotropin; Thy | 1986 |
Diagnostic value of free triiodothyronine in serum.
Topics: Evaluation Studies as Topic; Female; Humans; Hyperthyroidism; Hyperthyroxinemia; Hypothyroidism; Mal | 1986 |
Juvenile thyrotoxicosis.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Hungary; Male; Methimazole; Thyroid Hormones; T | 1986 |
Abnormalities in pituitary thyroid axis function tests in patients with paroxysmal supraventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pr | 1987 |
Erythrocyte zinc in differential diagnosis of hyperthyroidism in pregnancy: a preliminary report.
Topics: Diagnosis, Differential; Erythrocytes; Female; Humans; Hyperthyroidism; Pregnancy; Pregnancy Complic | 1987 |
Hypothalamic-pituitary-testicular axis in patients with hyperthyroidism.
Topics: Blood Glucose; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypo | 1988 |
[Primary hypothyroidism after the onset of thyrotoxicosis].
Topics: Adolescent; Adult; Female; Humans; Hypothyroidism; Male; Middle Aged; Thyrotoxicosis; Thyrotropin; T | 1988 |
Problems with asthma following treatment of thyrotoxicosis.
Topics: Adult; Asthma; Carbimazole; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Middle Aged; Re | 1988 |
T3-thyrotoxicosis in a schizophrenic patient--comment on triiodothyronine to mental function.
Topics: Adult; Humans; Male; Schizophrenia; Thyrotoxicosis; Triiodothyronine | 1988 |
The low physical working capacity of thyrotoxic patients is not normalized by oral antithyroid treatment.
Topics: Adult; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Physical Ex | 1988 |
Lacking evidence for release of thyroid hormones from circulating thyroglobulin during subtotal thyroidectomy.
Topics: Adult; Female; Humans; Male; Middle Aged; Thyroglobulin; Thyroidectomy; Thyrotoxicosis; Thyrotropin; | 1988 |
Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness.
Topics: Aged; Amiodarone; Diagnosis, Differential; Humans; Hyperthyroidism; Iodine; Male; Sex Hormone-Bindin | 1987 |
Massive thyroxine intoxication: evaluation of plasma extraction.
Topics: Aged; Coma; Female; Half-Life; Hemoperfusion; Humans; Male; Medication Errors; Middle Aged; Plasmaph | 1987 |
Potassium contractures and asymmetric charge movement in extensor digitorum longus and soleus muscles from thyrotoxic rats.
Topics: Animals; Contracture; Electrophysiology; Forelimb; Hindlimb; In Vitro Techniques; Male; Membrane Pot | 1987 |
Serum sex hormone-binding globulin in amiodarone-treated patients. A marker for tissue thyrotoxicosis.
Topics: Aged; Amiodarone; Female; Humans; Male; Middle Aged; Sex Hormone-Binding Globulin; Thyrotoxicosis; T | 1987 |
Silent thyroiditis.
Topics: Family Practice; Female; Humans; Male; Thyroiditis, Subacute; Thyrotoxicosis; Thyroxine; Time Factor | 1986 |
A freeze-fracture study of extensor digitorum longus and soleus muscle fibers from thyrotoxic rats.
Topics: Animals; Cell Membrane; Freeze Fracturing; Intracellular Membranes; Muscles; Rats; Sarcoplasmic Reti | 1986 |
Amiodarone-induced thyroid gland dysfunction.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Iodine; Male; Tachycardia; Thyroid Diseases; Thyroid Gla | 1987 |
The effect of methylthiouracil on the uptake of 131I-triiodothyronine by the red cells: a test for thyrotoxicosis.
Topics: Erythrocytes; Humans; Iodine Radioisotopes; Methylthiouracil; Thyrotoxicosis; Triiodothyronine | 1967 |